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 ABSTRACT 
 
KALLADAIPPU is the most common disease in our country. The evidence of the 
disease KALLADAIPPU was derived from YUGI VAIDHIYA CHINTHAMANI 800, by 
Dr.K.Anbarasu B.S.M.S (Page.No.283). The clinical features of KALLADAIPPU can be 
correlated with UROLITHIASIS in modern science. Urolithiasis is a term originated from 
three greek words “ouron” for urine, “oros” for flow, and “lithos” for stone. It is the 
formation of calculi which are formed or located anywhere in the urinary system (i.e kidneys, 
bladder, uretherae, urinary tract).  
           Many herbal and herbo-mineral formulations have been described in Siddha text 
books. One such drug SIRU NERUNJIL KUDINEER mentioned in the book of 
GUNAPAADAM MOOLIGAI (Page.no:597).  A total of 40 patients of both sex (20 OPD 
and 20 IPD) were selected and administered with the clinical trial medicine “SIRU 
NERUNJIL KUDINEER” 40 ml BID at PG Department of Pothu Maruthuvam, Govt. 
Siddha Medical College and Hospital, Palayamkottai. The whole study period is between 
August 2017 and June 2018. 
The clinical trial medicine was subjected to Biochemical, Physiochemical and 
Pharmacological studies. In clinical study 60% of out patients and 50% of In patients showed 
Good response. And 40% of Out patients and 50% In patients showed Moderate response. No 
Poor response. No Adverse reaction was found in this clinical study. The statistical analysis 
showed good significant value (P<0.0001). The Siru Nerunjil Kudineer is safe and effective 
and affordable cost in the treatment of Kalladaippu Noi (Urolithiasis).  
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CHAPTER-I 
INTRODUCTION 
1.1BACK GROUND                                                                                                     
Siddha system is a unique and historical medical system of India with strong 
philosophical foundation behind its medical science. It is the first system to emphasise 
that health and is the perfect state of physical, psychological, social and spiritual 
component of human being. The system strongly advocates proper food habits. If 
human being has any alteration in food habits, it will affect the vital elements of their 
body. According to Thiruvalluvar in Thirukkural says that, 
“liXhicz<zik!d{<c!lXk<K{<{qe<!
DX!hicz<jz!dbqi<g<G”!
The basic theory of Siddha system of medicine is “Food is medicine, Medicine 
is food”. 
 According to Siddha system, siddhars defined 96 principles as the constituents 
of the human being. In that PANCHABOOTHAM are the basic elements which are 
included as first section of 96 thathuvams in each and every bit of all the physical and 
subtle bodies i.e the human body and the universe. They are Aagayam (space), Kaal 
(air), Thee (fire), Neer(water), Mann(earth). 
 hivh<hi!H,kjlf<K!l{<fQi<!OkB!
! hiq!uiB!uigib!jlf<kqeiOz!
! Osvh<hismlis<sq!/!/!/!/!/!/!!
skgfic!
!!!!!!!!!!!!!!!!!!!!!!!Ofib<!fimz<!Ofib<!Lkz<!fimz<!hg<gl<!6!
 The physiological function of the human body is mediated by VATHAM, 
PITHAM, KABHAM i.e three Uyir Thathukal formed by the combination of five 
basic elements.These elements govern the physio-biological and physio-pathological 
functions of our body and is responsible for all kinds of illnesses and sufferings of 
mankind. 
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 VATHAM is formed by the space and air. 
 PITHAM is formed by the fire. 
 KABHAM is formed by the earth and water. 
The first phase in human life is attributed to vatham, the middle phase to 
pitham, and the last phase to kabham. 
“uiklib<!hjmk<K!
hqk<k!ue<eqbib<!gik<K!
Osk<Kl!sQklib<Kjmk<K”!
Okve<!lVk<Ku!hivkl<!
 Thus the three humours are said to occupy the lower, middle and upper parts 
of the body respectively and maintain their integrity and function. The normal 
equilibrium of three humours is considered as health and its disturbance or imbalance 
leads to a diseased state. The Siddha medicine has been claimed to revitalize and 
rejuvenate the metabolic dysfunctions in organs than cause the disease and maintains 
the bio-regulating factors namely Vatham, Pitham, Kabham. 
 The seven physical constituents UDAL THATHUKAL such as 
Saaram(plasma), Seneer(blood), Oon(muscle), Kozhuppu(adipose tissue), Enbu 
(bone),  Moolai(bone marrow),  Sukkilam(semen). 
In diagnosis, examination of eight items is required which is commonly 
known as “EN VAGAI THERUVUGAL” 
  
 Naadi - Pulse   Niram - Colour 
 Sparisam - Touch   Vizhi - Eyes 
 Naa - Tongue   Maalam - Stools 
 Mozhi - Voice   Moothiram - Urine 
Siddhars are the spiritual scientists and they have classified diseases into 4448  
numbers. One among them clinical entity is “KALLADAIPPU NOI”. Similarly in 
modern medicine it is compared to “UROLITHIASIS”. 
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In yugi vaidhiya chinthamani- 800, urological disorders are classified into 
two categories such as 
1) Neerinai perukkal noi – where the urination will be excess . 
2) Neerinai arukkal noi – where the urine output will be reduced . 
The disease KALLADAIPPU is placed under Neerinai Arukkal noi. One of 
the works of yugi munivar, Kalladaippu is dealt under the chapter KALLADAIPPU 
ROGAM NITHANAM. Yugi documented the sequential order of dissemination of 
knowledge of Kalladaippu from lord shiva to till yugi for the benefit of the people 
living in the world. 
 Urolithiasis is the process of forming stones in the kidneys, bladder, and or 
uretherae. It is the most common disease of present society due to modern life style, 
abnormal diet habits, and low fluid intake. The disease is denoted by the sudden 
obstruction of the urinary tract, while passing urine by excretion there is presence of 
small sand like granules. The diagnosis of calculi can be confirmed by ultra sound 
examination, urine & blood test are also commonly performed. 
The efficacy of invasive therapies such as extra corporal shock wave 
lithotripsy and ureteroscopy has been proven by several studies. However, these 
techniques are not risk free and they are problematic and quite expensive and 
complications. 
Several drugs and medicines are available for treating KALLADAIPPU NOI. 
However, clinical trials on the treatment of Kalladaippu noi have not yet been 
undertaken the medicine “SIRU NERUNJIL KUDINEER” (Internal), it has to 
mention in GUNAPAADAM MOOLIGAI (Pg.no.597) text book. It is well known for 
its diuretic and lithotriptic action in treating the disease KALLADAIPPU. So I have 
chosen this medicine for my dissertation work. 
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1.2 AIM AND OBJECTIVES: 
AIM OF STUDY: 
To pre-clinical, clinical study about Siddha formulations of “SIRUNERUNJIL 
KUDINEER” in the management of “KALLADAIPPU NOI” (urolithiasis). 
 
OBJECTIVES: 
1. To collect the various literary evidence for Kalladaippu disease. 
2. To study the Siddha formulation of the drug SIRU NERUNJIL KUDINEEER 
in the treatment of KALLADAIPPU (UROLITHIASIS) for the clearance / 
reduction in the size of the calculus and clinical symptoms. 
3. To collect about the disease Kalladaippu noi with deep observation of 
aetiology, clinical features mentioned in various Siddha literatures and also in 
modern text books, diagnosis and prognosis. 
4. To confirm the diagnosis in Siddha system with the help of modern parameters 
during and after treatment in all patients.  
5. To perform urine analysis, haematological studies and ultrasonography for all 
patients. 
6. To perform stone analysis in selected cases. 
7. To undertake biochemical physiochemical microbial analysis of the clinical 
trial drug. 
8. To evaluate pharmacological activity of my trial drug SIRU NERUNJIL 
KUDINEER. 
9. To assess the safety profile of the trial drug. 
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CHAPTER-II 
REVIEW LITERATURE 
 
2.1 SIDDHA ASPECT 
 Siddha system of medicine is an old age traditional system with unique 
properties is not only treating a disease but gives us an immense perception and 
approach to lead a healthy life. Among the various diseases, “Kalladaippu Noi” is one 
of the most common diseases. Several preventive and causative treatments are found 
in various siddha literatures for Kallaidaippu Noigal. 
 In Siddha literature, Kalladaippu noi is mentioned by Yugi Munivar in “Yugi 
Vaidhya Chinthamani 800”. It is one of the urinary disease which come under 
Neerinai Arukkal Noigal. 
“fQvqV!uqjeg<!G{k<jk!
fQbxq!uqvqk<Ks<!osiz<Ouil<!
fQvqje!ohVg<gozie<Ox!
fQvqje!bVg<g!ozie<Ox!
fQvqpqUmOe!ogiz<Zl<!
fQIg<gm<M!uqjegotie<X”!
Okve<!gvqsz<!
Ofib<fimz<!Ofib<!Lkz<!fimz<!.!3l<!higl<?!hg<gl<!531 
2.1.1OuXohbv<gt<< << << <!)SYNONYM)            
       ASHMARI ROGAM 
2.1.2 -bz << <<!)DEFINITION) 
kalladaippu noi is defined by various authors, 
 a) In “Agathiyar Gunavagadam” , kalladaippu noi is defined as below: 
“kioee<x!&k<kqvk<kqz<!fx!fxoue<X!
kr<gqbOkiI!ohicobEl<!l{z<kieh<hi!
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uioee<x!sqxqbokiV!gz<ziukh<hi!
utlig!uf<KuqPl<!Ofib<g<G!kiOe!
Woee<x!n^<lvq!Ovigole<x!Ohvil<!
wtqkigg<!gz<Zgt<kie<!uqPGl<OhiK!
Ogioee<x!G{<cg<gib<!&k<kqvg<Gpzh<hi!
G{lie!&k<kqvh<jh!fQi<k<kijvg<!OgOt”!
Ogtmi!Le<!Gxqbqz<!wvqs<sz<!g{<M!
ogcbig!Oukjegt<!gim<Mlh<hi!
uitmi!sqxqbokiV!gx<gt<kiOe!
utlie!&k<kqvh<jh!Gpz<!upqh<hcbib<k<!
Oktmi!uVl<OhiK!kqOvgf<ke<eqz<!
okiqh<hK!Ohiz!bqVOukje!osb<Bl<hiV!
fitmi!gx<gt<ki!eqxr<gquqm<miz<!
fzlie!Oukjegt<kie<!kQVl<hiOv”!
ngk<kqbI!G{uigml<!hg<gl</7!
 According to Agathiyar, Kalladaippu noi defines as “Deposition of crystals 
which look like sand followed by small size of stones which is excreted in the  urine. 
Sometimes the stones obstruct in the kidney ureter, urinary bladder and urethra. When 
the stones reaching the uretheral orifice, intense burning sensation in the genital area. 
Then the stones get expelled and pain is relieved. 
b) In “Jeeva Ratchamirtham” 
 Kalladaippu noi is defined as pain present in abdominal region particularly 
around the umbilicus, fever, dysuria, urine smell like that of goat urine, chills, 
anorexia are common features of this disease. 
c) In “T.V.Sambasivam Pillai Agarathi” 
 Large concentration of stones in the bladder or Kidney produces calculus or 
gravel. It causes difficulty in passing urine. 
d) In “Siddha Maruthuvam” 
 Sudden obstruction of flow of urine during micturiation, pain in the tip of the 
penis in males and clitoris in females burning sensation in uretheral orifice, pain 
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radiating from loin to groin, presence of sand like stones in the urine are the 
symptoms of this disease. 
2.1.3 Ofib<!uVl<!upq< << << <  (AETIOLOGY) 
a)  According to Maanmurugiyam are mentioned as, 
  gVfQvmg<gz<!uqjvbqz<!nchmz<!
! ! ! fQiqbf<kig<gz<!sqX!fQvmg<gz<!
! ! utqOfib<lqVg<G!L{Ul<!yPg<gLl<!
! ! ! gjmh<hqck<kqMkz<!OlgLkx<!hz!
! ! hq{qBxz<!wPlqju!bch<hjmbigg<!
! ! ! gz<zjmh<Hobe<El<!gMl<hq{q!uqjtBl<!
! ! utqbK!lQxqObiM!lz<ziK!
! ! ! gVfQoviMr<!gzf<K!fQvgk<Ks<!
! ! sqXfQi<g<!gpQU!okiMk<kiZl<!
! ! ! ne<eju!gz<ozek<!kqvTole<h!!!!!!!!!!!!hg<gl</229!
 The above poem described as, 
 Trauma on testies, suppression of urine & semen 
 Derangement of humour in blood. 
 Excessive indulgence in sexual activity. 
 Inflammation of bladder. 
 Syphilis, stagnation of urine in urinary treat. 
 Dryness of semen causes formation of stones. 
 Increased intake of food that cause flatulence. 
b)  According to Siddha Maruthuvanga Churukkam. 
“fQiqjek<kMk<kz<!osb<bqe<!
! fQi<g<gm<Mk<!Kuivl<!H{<{il<!
hiiqMR<!sf<K!sf<kqz<!
! h{<HX!OfiukiGl<!
Ofiqzr<!gbVr<!gilqbl<!
! fqs<sbOfikz<!osb<Bl<!
hiiqeq!zihie!uiB!
! h{<Hxs<!OsVle<Ox”!!!!!!!!!! ! ! ! !!!!!!
hg<gl<!323!
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 The above poem said when urine is ceased deliberately, obstruction of urine 
flow, ulcer in the uretheral orifice, pain in the glans penis, increased abaana vayu in 
the abdomen, it leads to 
“Sg<gqzf<kjeb!mg<gqe<!
SvLmeQIg<gm<!miGl<!
hg<glir<jggiz<!sf<K!
hiv!Ofib<!upqbqxr<Gl<!
lqg<gliI!OfiB{<miGl<!
lqGk<kqMl<!hqvOl!gf<kie<!
kg<g!OkiI!OhiKligqe<!
kvqk<kqMl<!uiBg<!%Ox”! ! ! hg<gl<!.!323!
 The natural urges of human beings, semen needs to be discharged regularly. 
The above poem said emphasizes that deliberate cessation of seminal discharge 
results in fever, lumbar pain, oliguria, and white discharge. 
c)  According to Yugi Vaidhya Chinthamani 800 
“oktqf<kOkiI!gz<zjmh<H!dx<hk<kq!Ogtib<!
sqxqKfim<!omimr<gqOb!Olgf<!ke<eqz<!!
ktqf<kOkiI!szh<jhbq!Zkqvk<!Okib<f<K!!
sf<ksk<!kigOu!hVk<Kg<!ogit<Tl<!!
utqf<kOkiI!uikhqk<kr<!Ogihqk<!kg<giz<!!
uf<KohVr<!gz<zib<!fQI!upqb!jmk<K!!
ftqf<OkiI!fiZuqkg<!gz<z!jmk<K!f{<hie!!
uvziX!fim<mg<!OgOt”!
himz<!836?!hg<gl<!394< < << < << < < !
“gzr<gqeOkiI!k{<{QIkie<!Gck<k!OhIg<Gr<!
gz<ozZl<H!lbqi<l{<kie<!gzf<ke<!ek<kqz<!!
nzr<gqeOki!ve<er<g!tVf<k!ziZl<!!
nPgOziM!&k<kh{<m!lVf<k!ziZl<!!
lzr<gqeOkiI!lih<h{<m!lVf<k!ziZl<!!
lf<kk<kqz<!uib<uie!hkiIk<kf<!ke<je!!
Kzr<gqeOkiI!Vsqke<eqx<!Sjuk<k!ziZl<!!
SVg<gib<g<gz<!zjmh<Huf<K!Okie<Xf<!kiOe”!
himz<!<<< 838!hg<gl<!394< << << < !
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In Chronic (syphilitic disease) Mega Noi the semen will stagnate for a long 
time in the urinary tract so it will obstruct the urinary flow so urinary contituents will 
easily deposit on the urinary tract and form the stone. At that time due, to increased 
Vatham and Pitham humour, the small stones becomes larger in size and block the 
urinary passage. 
2.1.4 ohiKGxq!G{r<gt<<< << <<(COMMON SYMPTOMS) 
df<kq!ke<eqEl<!nke<!gQp<!lVr<gqEl<!
uqjvfvl<!hqck<Kl<!OfiU!Okie<xz<!
sqXfQi<!ofxqbqz<!gz<Zvk<kMh<hqe<!
Liqk<K!Liqk<K!fQi<!uQp<f<kqMkz<!
gz<zK!uqzgq!fqe<xqce<!sqXfQi<!
oktqf<kqe!lR<st<!fqxk<kq!oziPkz<!
wElqju!gz<zjm!ohiKGxq!obe<h!
Ofib<!fimz<!Ofib<Lkz<!fimz<!Lkz<higl<!hg<gl<!538!
 
 Gradual or sudden obstruction of flow of urine 
 unbearable pain (i.e agonizing pain) in the penis 
 Burning and scanty micturiation and Haematuria 
 Colicky pain radiating from loin to groin region, lower abdomen, 
urethera & genitalia if the calculus is irregular in shape. 
  
2.1.6ujggt<<<<!. (CLASSIFICATION) 
A)   In “Yugi vaidhya chinthamani 800” 
“Okie<xqmOkiI!fizqeqm!filr<Og!tib<!
SXg<gie!uikk<kqe<!gz<z!jmh<H!
H,e<xqbOkiI!hqk<kk<kqe<!gz<z!jmh<H!
Hv{<mOkiI!sqOzm<Mlk<kqe<!gz<z!jmh<H!
kQe<xqbOkiI!okif<klir<!gz<z!jmh<H!
Okgk<jkh<!hx<xqOb!sqxqK!gizl<!
kie<xqOb!szh<jhbqz<!uf<kq!pqf<K!
sVuqOb!zqr<gk<kqx<!xvqg<Gf<!kiOe”!
himz<!839?!hg<gl<!395!
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 The above poem mentioned, that Kalladaippu noi is classified into four types. 
They are: 
1. Vali Kalladaippu 
2. Azhal Kalladaippu 
3. Iyya Kalladaippu 
4. Mukkutra Kalladaippu 
Vali Kalladaippu: 
“kvqk<K!fihqg<G!SVg<glib<!Gx<xqs<!
szlzf<kie<!uQpilx<!xl<h!ligq!
uvqk<KOl!zqr<gk<kqz<!uzqB!ligq!
lVuqbOkiI!ohik<kqobziR<!Svf<K!gm<c!
kqiqk<kqOb!gqjmg<ogimih<!hqvm<mzigqk<!
Okl<hqOb!&s<Slib<!ubqX!Lh<Hl<!
dvqk<kOkiI!sjkOhiz!duIh<H!liGl<!
Yr<gqbOkiI!uikg<gz<z!jmh<H!kiOe”!
himz<!83:?!hg<gl<!395!
 Acute pain felt just below the umbilical region and penis. Scanty 
micturition obstruction of urine flow. Sometimes mucous discharge in urine, patient 
unable to sit. 
Azhal Kalladaippu 
“njmh<higqs<!szf<kiE!lVu!zigq!
nbr<gis<sqs<!osiVgqeix<!OhiOz!gi[l<!
Hjmh<high<!ohix<xqobr<!Gl<H!Pg<gligqh<!
H,m<Mh<Ohiz<!hqGuigqh<!hqvm<m!ziGl<!
ljmh<higq!dkqvfqx!libg<gz<!zigq!
uf<kpqf<K!zqr<gk<kqz<!lim<cg!ogit<Tl<!
Gjmh<higqg<!Gx<xzib<g<!%s<szigqg<!
Gkm<MOl!hqk<kg<gz<!zjmh<H!kiOe”!
himz<!841?!hg<gl<!396!
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It is characterized by reduced urine output with characteristic burning 
sensation (similar to introducing a root hot iron needle into the urethera) Excretion of 
small blood stained stones. Causing pricking pain & tenderness. 
Iyya Kalladaippu 
“kiei!okih<HtqOz!uqz<Z!Ohizs<!
szqbilx<!Svf<KOl!sx<Ox!Gx<Xl<!
Weie!giOziM!jggt<!sf<K!
-Mh<Hkie<!Gjms<szi!bqsqU!gi[l<!Oueie!
zqr<gk<kqe<!ou{<jl!ke<eqz<!
uqxuqoxe<!OxgMh<higq!uqbIjubiGl<!Okeie!
ouTh<Hg<gz<!sqXgz<!zigqs<!
sqg<gzib<!uf<kqxr<GR<!Osm<hf<!kiOe”!
!himz<<<<842!hg<gl<< << << <!396!
It is characterized by excruciating pain in the umbilical region.  Pain in the joints 
of upper and lower extremities. profuse sweating and expulsion of smell white coloured 
stones in the urine. 
Mukkutra Kalladaippu 
“uf<kqxr<Gl<!fQIk<kijv!bcbqx<!xiEl<!
liuVk<k!L{<migq!uzqB!ligq!
ofif<kqxr<gq!fQIkiE!lVuq!hiBl<!
ofibkie!sqXl{z<!Ohiz<!ofiXr<gq!gz<zie<!
sf<kqvr<gq!fQIupqbqz<!uf<K!uQPl<!
kig<gie!sqxr<jgg<gz<!kqeolie<!Xg<G!
Kf<kqxr<gqk<!kqef<kqeL!lqpf<K!ogiz<Zl<!
okif<klir<g!zjmh<Hs<!$m<cm<!miOb!
himz<!843?!hg<gl<!397!
Severe pain felt below the uretheral region. Irregular urine output. It is 
Characterized by disintegration of stones into small like granules excreted in the urine 
and semen.                      
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B) In “Noi Vilakkam” 
utqLkz<!&e<xqEf<!Okie<x!ziZl<!
gVfQi<!ke<eqx<!Okie<x!ziZl<!
! gz<zjm!fiz<ujgh<!hMole!olipqh!
According to Noi Vilakkam, Kalladaippu Noi is classified into 4 types. 
1. Vali Kalladaippu 
2. Azhal Kalladaippu 
3.  Iyya Kalladaippu 
4. Karuneer Kalladaippu 
utqg<gz<zjmh<H!GxqG{r<gt<;!
hmi<lqgh<!hMk<kz<!hx<gt<!gck<kz<!
fMr<gz<!df<kqBl<!GxqBl<!hqjskz<!
gsMgQp<!stqobiM!gpzz<!nPkz<!
sqXfQi<!Ktqk<kz<!we<hUl<!hqxUl<!
utqbqe<!gz<zjmg<!Gxqobe!olipqb!
gXk<KR<!squf<Kl<!Ljegt<!hvf<Kl<!
utqbqe<!gz<zK!ucUE!ole<h!!!!
!.Ofib<!uqtg<gl<!
• Tongue biting, palpitation and chills. 
• Lower abdominal colic and pain in the external genitalia. 
• Dribbling of Urine, The Stones are blackish red in colour. 
npz<gz<zjmh<H!GxqG{r<gt<;!
“Sm<ome!fQvqbl<!lqgouh<!hqMk<kZl<!
OfikZl<!nezg<!gz<zjmg<!GxqOb!
squf<Kl<!gXk<K!lR<s!tigqBl<!
Osr<GV!ucuqz<!gz<zK!Okie<Xl<”!
!.Ofib<!uqtg<gl<!
• Burning micturition, Dysuria 
• Passing reddish black or yellow coloured stones 
13 
 
Jbg<gz<zjmh<H!GxqG{r<gt<;!
“fQvqbr<!Gk<kz<!kq{qk<kz<!Gtqk<kz<!
wElqju!Jbg<!gz<zjmg<GxqOb!
ouTk<Kl<!Okeqx!ligqB!olitqIf<Kl<!
ohVuc!Ujmk<kil<!Jbg<!gz<zjm”!
.Ofib<!uqtg<gl<!
• Pricking pain with severe intensity while passing urine.  
•  Fever with rigors 
• White or honey coloured shining or luminant large size stone  expelled. 
gVfQIg<gz<zjmh<H!GxqG{r<gt<;!
“fQvqbl<!Ofikz<!sqXfQI!kjmh<hmz<!
uqjvuqz<!gqMkz<!wElqju!hqxUl<!
gVfQIg<!gz<zjmg<!Gxqobeolipqh”!
.Ofib<!uqtg<gl<!
 Sudden or gradual obstruction to flow of urine  
 Excessive Vali kutram breaks the stones into small and large size crystals and 
expels along with urine, Sudden stoppage of urine stream 
 Retention of urine, Abdominal pain, Loss of taste, excessive thirst. 
C) In “Dhanvanthiri Vaithyam II – Part” 
1. Kallarippan 
2. Pitha ashmari 
3. Silethuma ashmari 
4. Sukkila ashmari        Page 9 & 10 
Kallarippan: 
“Sk<KfQI!fitf<ke<eQx<!Sg<gqzf<ke<eQx<!sqOzx<hel<hqk<klQ!
KzIk<kz<!gz<zib<!hQsgqfQ!jmk<Kg<!ogit<Tr<!ogik<KfQ!
vqx<XuQPr<!ogih<Ht<Ofi!Gml<H!giBR<!sqk<ki!bVsq!
B{<miR<!OsIf<kgz<!ozvqh<hieiOl”!
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It is learnt from this poem that when kabam and pitham increase, urine and 
semen dry up, resulting in the formation of stone which in turn lead to obstruction of 
urinary tract, dysuria, pricking pain in umbilicus, fever and anorexia. 
Silethuma ashmari: 
“fQI!uV!kitk<!ke<eqz<!fqe<XfQI!
sqXk<Kg<ogi{<MOsiIf<kVl<!squh<H!ou{<jl!Sg<gqzl<!
Ohiz!uQPl<!OhIohx!fiziolm<Ml<!hqe<elib<!gz<Z!
uQPl<!WIohX!sqOzx<hek<kqz<!ns<lvq!we<eziOl”!
This poem states that when the calculus arrive the uretheral orifice, the 
volume of urine gets reduced gradually, leading to Oliguria. Ultimately, the stone is 
broken into four to eight pieces and pass through the urine. 
Pitha ashmari: 
“ohb<Bl<fQI!fitk<!ke<eqz<!hqk<kk<ki!oziqh<!ohPf<Kosb<BU]<!
{k<kiz<ouf<K!Osr<ogim<jm!Ohix<gz<!Z{<mil<!fb<bOu!
kjegt<!osb<Bl<!fuqz<!G{l<!hqk<kf<ke<eqz<!wb<kS!
lvqobe<oxLe<!eqbl<hqe!vxquqe<!lqg<ogiI”!
It is evident from this poem that when pitham accumulates in the urethral 
orifice, severe pain will result in along with burning sensation. 
Sukkila ashmari: 
“Sg<gqzl<!uVr<gizk<kqz<!kl<hqk<kix<!Sg<gqzf<kie<!
lqg<ggz<!zigqoul<hq!uqkelib<!fQIuqmilx<!
sqg<gqfQI!uqpi!lzr<Og!l{z<!uqPl<!ouTg<Gf<Okgl<!!
lqg<G{R<!Sg<gqziS!lvqbsik<!kqbole<OxiOk”!
If semen discharge is ceased it gets concentrated and dried up in the uretero-
vesical junction, preventing the flow of urine which results in anuria. Under this 
condition sand grains like stones pass through the urine and anemia occur. 
D) In “siddhar Aruvai Maruthuvam” 
Kalladaippu noi is classified into four types. 
1. Vali kalladaippu 
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2. Azhal kalladaippu 
3. Iyya kalladaippu 
4. Veneer or Manal kalladaippu               Page-<223 
E) In “Roga Nirnaya Saaram under Roga Nithanam” 
Ashmari rogam is classified into five types: 
1. Vatha kalladaippu 
2.  Pitha kalladaippu 
3.  Kapha kalladaippu 
4.  Sukkila kalladaippu 
6/ Swargara Ashmari or Kalladaippu rogam/!!!!!!!!!!!!Page-<8:?91!
 
1. Vatha ashmari 
Urine turns to black in colour, dribbling, grunting teeth and rubbing of penis. 
2. Pitha ashmari 
Tip of penis turns to black in colour and urine turning to red, white and yellow 
in colour 
3. Kapha ashmari 
Urine becomes white in colour and highly viscous and flows down like honey. 
4. Sukkila ashmari 
Cessation of seminal fluid discharge during sexual intercourse leads to 
retention of semen in vas deferens or spermatic cord, which get dripped up by 
vatham. This condition eventually results in inflammation of testis and lower 
abdominal pain. 
5. Swargara ashmari or kalladaippu rogam 
Semen is retained in the spermatic region and gets dried up. The dried semen 
turns to stones in the size of sand, green gram, ground nut and get mixed up with 
urine and pass through the urethral orifice. 
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F) In “Anubhava vaidhiya Devaragasiyam – I Part” 
1. Vatha ashmari 
2. Pitha ashmari 
3. Kapha ashmari 
4. Sukkila ashmari 
5. Swargara ashmari or kalladaippu rogam                              Page-131 
G) In “sikitcha rathna deepam – Vaidhya Chinthamani – II part” 
1. Vatha kalladaippu 
2. Pitha kalladaippu 
3. Kapha kalladaippu 
4. Mukkutra Kalladaippu                                                          Page-140&141 
 
1.Vatha kalladaippu 
The symptoms include acute pricking pain in the lower abdomen, obstruction 
of the flow of urine, scanty micturition, pain in the penis, making the patient unable to 
sit, crying, flatulence, presence of albumin in the urine and mucous discharge with 
urine. 
2.Pitha kalladaippu 
The symptoms are obstruction of the flow of urine, burning sensation in the 
urethral orifice (the burning sensation refers to melting point of iron put on the 
external meatus), acute pain in the urethra and expulsion the small blood stained 
stones. 
3.Kapha kalladaippu 
In this kalladaippu, patient suffers from severe pain in the lower abdomen, 
pain radiating towards the thigh, joint pain associated with rigor and pain in the tip of 
glans penis. Finally, small white coloured stones are expelled along with urine. 
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4.Mukkutra kalladaippu 
Pain in the urethral orifice, pain during micturition, presence of small sand 
grain like stones in urine are the cardinal features of mukkutra kalladaippu. 
2.1.6 SOME DISEASES ASSOCIATED WITH KALLADAIPPU NOI IN 
SIDDHA TEXT:  
dg<giv!$jz<<< !)UKKARU SOOLAI) 
“Gk<K!Lk<giv$jz!bqe<G!{f<kie<!
OgiIjubib<!uqziUkeqz<!LKgqz<!ofR<sqz<!
nk<kq!bqeqz<!fihqbqz!hielir<G!kk<kqz<!
nkqg!Ke<lir<gqsf<kie<!utIf<K!Oluqh<!
hk<Kl{x<!hMg<jgOhix<!szk<K!uivh<!
hkqofVg<gq!&k<kqvlir<!gqvqs<sq!B{<mib<k<!
kk<Ksmr<!gMh<ohMk<K!lkqg!zr<gqk<!
ktIs<sq!obiMlbg<glib<k<!kt<Tf<!kiOe”!
!!!!!!.!B,gq!juk<kqb!sqf<kil{q!–!911!himz<!344?!hg<gl<!99!
 Excessive growth of muscles in chest region, back of trunk, umbilicus, anal 
and urethral orifice followed by stricture of uretheral orifice by sand like crystals 
blocked in urethera causes dysuria, tiredness, body pain occurs. 
2.1.7 Lg<Gx<x!OuXhiMgt<< < << < << < < : (PATHOLOGY) 
“uiBuqeiz<!lzl<!szr<gm<cMl<!
hqiqk<kqML<!hqk<kl<!OhvR<!szk<kqeiOz”!
sqk<k!lVk<Kuir<g!SVg<gl<!hg<gl<!.!265 
Alteration in diet and lifestyle causes the vitiation of the vatha humour for 
sufficiently enough time, which can further cause the imbalance in either of the other 
two humours and hence pitham is also deranged resulting in urolithiasis. Vali is 
responsible for dryners and Azhal is responsible for the heat. This causes decrease in 
body fluids and increase in concentration of urine and thereby the crystal grows and 
aggregation takes place in the urinary passage. As (kezhnokkukal) “Abanan” one of 
the component of ten vayu, is strongly responsible to expel the deposits that will be 
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automatically washed out in urine. If Abanan is not strong enough, the deposited 
material will not be expelled and pave way for renal stones. 
SIDDHA PATHOLOGY & SCIENTIFIC ASPECTS OF KALLADAIPPU 
 
Indiscipline in Food and Lifesytle 
 
           Vitiated vali      Vitiated Azhal 
 
                           Dryness   Heat 
 
   
 
 
 More over Vatham is responsible for maintenance of 14 reflexes including 
micturition. Therefore body pain, pricking pain in external genitalia and constipation 
seen in urolithiasis (Kalladaippu) due to altered vatham humour. 
 Pitham has direct link with urine (i.e) “Pitham Siruneeril Adangum”. 
Therefore symptoms of darked yellow urine, sometimes reddened urine seen in 
Kalladaippu due to elevated pitham humour. 
 Decreased Kapham humour prones the body constitution to dryness and heat. 
 All these derangements create the alterations in biochemical parameters of 
Kidney function form the symptoms of urolithiasis. 
 
  
Concentration of 
urine 
Crystallization of  
Urine 
Formation of urinary 
stones 
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2.1.8 PRINCIPLES OF SIDDHA DIAGNOSIS IN UROLITHIASIS: 
 Siddhars investigate the cause of the disease the signs and symptoms, 
complications if any and anatomical (udal kooru) changes to arrive at a diagnosis of a 
disease. They examine both the body and the disease together to arrive a conclusion 
regarding the condition or diseases. 
 They followed two paths called “Noi naadal” in simple terms defined as the 
approach to the disease and “Noi Mudhal Naadal” which is determination of 
aetiologyof the disease. These diagnostic tools designed by siddhars that they can also 
determine the risk factor and help in early prediction of the illness. The following are 
the diagnostic methodologies of urolithiasis in Siddha. 
 
S.No. Thathuvams Affected basic principle 
Symptoms of 
Kalladaippu 
1. Uyir thathukkal (3) 1. Vatham (10) 
Abanan 
Udhanan 
Scanty mituriation, 
Haematuria, Dysuria, 
Nausea and vomiting 
 
 2. Pitham (5) 
 Saathagapitham 
Dysuria, oliguria 
 
 3. Kabham (5) 
  Santhigam 
pain present in the joints 
2. Udal thathukkal (7) 1. Moolai (bone 
marrow) increased 
oliguria 
  
2. Sukkilam (semen) 
increased 
renal calculus 
3. Iymboothangal (5) 1. Vayu (Air) obstruction in genitalis 
  
2. Thaeyu (fire) Dryness, heat burning 
sensation 
  3. Appu (water) reddened urine 
4. Iymporial / Iyampulangal (5) 
1.Mei koocherithal 
5. Kanmenthiriyam / Kanmavidayam (5) 
1. Eruvai constipation 
20 
 
6. Aasayam (5) 1. Salavasayam oliguria 
  
2. Sukkilavasayam pain and burning sensation 
in external genitalis 
7. Yakkai (3) (General 
characters) 
1. Vatham “Siruneer porumi Kaduthu 
vizhum” 
  
2. Pitham “Neerum uyarnthu 
sivappagum” 
8. Manikkadai 
1. 9 ¼  “Neer kaduthu siruthu 
irangam”. dysuria and 
stranguria 
  
2. 6 ¾  proned to urolithiasis in 
3years of time 
9. Thinai (5) 1. Muthuvenil 
2. Karkalam 
Affected 
10. Kaalam (7) 1. Neithal 
2. Mullai 
Affected 
 
2.1.9!Ofib<!g{qh<H!Ljx< << << <  (DIAGNOSIS AND PROGNOSIS) 
 The Diagnostic methodology in siddha system in unique and it is made purely 
on the basis of clinical acumen of the physician. In “Piniyari muraimai” the following 
principles are 
1. Poriyaal arithal - Physical examination 
2. Pulanaal arithal - Clinical examination 
3. Vinaathal  - Medical History 
1. PORIYAAL ARITHAL : It means understanding by the five organs of perception. 
 Mei – ooru (somatic sense) to feel all types of sensation 
 Vai - suvai (taste) for knowing taste. 
 Kan - oli (vision) for vision 
 Mookku - Natram (smell) for knowing the smell 
 Sevi - osai (sound) for hearing 
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2. PULANAAL ARITHAL : It means understanding by sensing the objections. 
 Kai - All Manocurves 
 Kal - Walking 
 Vai - speaking 
 Eruvai - Defecation 
 Karuvai - Reproduction 
3. VINAATHAL (Interrogation) 
 The first step in diagnosing a disease by knows their personal history of the 
patient through Interrogation. The physician should interrogate the patients name, age, 
native place, socio economic states, food habits, personal habits, present complaints, 
of history of present illness, history of past illness, through this applied eight tools of 
investigation (i.e) “Envagai Thervugal”. 
2.1.10 w{<ujgk<!Oki<Ugt<;< < < << < < << < < < !
! “ngk<KX!Ofijb!gvk<kil!zgl<Ohiz<!
hGk<kxquQi<!fich<!hiqsl<!.!okiGk<k!fqxl<!
gm<Mujgs<!osiz<olipq!g{<m!lz!&k<kqvl<!fi!
wm<Mujg!biZ!lxquQi<”!
.ngk<kqbi<!juk<kqb!sqf<kil{q!ou{<hi!5111!
“fic!hiqsl<!fifqxl<!olipquqpq!
lzl<!&k<kqvlqju!lVk<KuviBkl<”!
.Okjvbi<!
“olb<Gxq!fqxf<okieq!uqpqfiuqVlzl<!jgg<Gxq”!
.Okjvbi<!
 According to Agathiyar vaithiya chinthamani venba 4000 and saint therayar, 
the Envagai Thervugal (Eight types of diagnostics) include, Naadi(pulse), Naa 
(tongue), Niram(colour), Mozhi(voice), Vizhi(eyes), Maalam(faeces), Neer(urine) and 
Sparisam (touch & palpation). 
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In “Gunavagada Naadi” about the Envagai Thervugal as following. 
“kv{qBt<t!uqbikq!ke<je!bm<mir<gk<kiz<!
kieqbxqb!Ou{<MuK!ObOki!oue<eqz<!!
kq{qbOkiI!ficg{<gt<!sk<kk<OkiM!
Okgk<kqeK!hvqsl<!uV{l<!fig<G!
bqv{lz!&k<kvliuqjug!otm<Ml<!
bqkl<hmOukie<!hiIk<K!Gxqh<Hr<g{<M!
hv{Vtiz<!ohvqObiIgt<!hikl<!Ohix<xq!
h{<H!kuxilz<!h{<ckR<!osb<uQOv”!!! ! !
hg<gl<!< << << < .!23:!
 In “Agathiyar vaithya vallathy” to apply the envagai thervugal for 
diagnosis of the disease. 
“okiGg<gZx<x!nm<muqk!hvQm<js!ke<je!
Kzg<gLXl<!h{<ckOv!oktqukigh<!!
hMg<giqb!ficjb!fQ!hqck<Kh<hiV!!
hgIgqe<x!uiIk<jkjbh<!hiI!fiju!hiV!!
uGg<gvqb!Okgole!okim<Mh<!hiV!!
utlie!svQvk<kqe<!fqxk<jkh<!hiV!!
sgqg<gvqb!lzk<jkh<!hiV!szk<jkh<!hiV!!
siIf<k!uqpqkjeh<!hiIk<K!oktquib<!giO{!!
fQcb!uqpqbqeiZl<!fqe<x!fig<Gxqh<hqeiZl<!!
uicb!OleqbqeiZl<!lzoliM!fQvqeiZl<!
$cb!uqbikq!ke<jes<!Sgl<ohx!nxqf<K!osiz<Oz”!
ngk<kqbI!juk<kqb!uz<zikq!
1. Naadi (pulse) 
 Naadi is nothing but the manifestation of the vital energy that sustains the life 
within our body. It plays an important role in “Envagai Theruvugal” and it has been 
considered as foremost thing in assessing the prognosis and diagnosis of various 
disease. Any variations occurs in three humours it is reflected in naadi. These three 
humours organize, regularize and integrate basic functions of the human body. So, 
Naadi serves as a good indicator of all aliments. 
 
23 
 
“uqPGl<!sqzOfvl<!uqMhm<M!fQOviMl<!
yPgqb!uiBUl<!yKr<gqeiz<!OfigiK!
uPgqb!lf<kk<kiz<!uiBuf<Ok!Hgqz<!
gPlq!LkqIf<kqMl<!gz<ozvqh<H!NGOl”!
!
kqV&zI!gVg<gqjmjuk<kqbl<!711!
 The above line mentioned that the Vatham and Mantham combined together, 
Kalladaippu noi may occur. 
“njxf<Okil<uik!OvigqBmz<!
npxg<{<LgLl<!hz<lzLl<!
fqjxf<k!uqpqbqz<!fQI!ucBl<!
fQ{<m!fiU!gXk<kqmUl<!
kqjxf<kLt<tib<!kieqVg<GR<!
sqX!fQI!ohiVlq!gMk<K!uVl<!
djxf<k!fQVr<gVgVk<K!
Ljxbib<!OvigL!L{<miOl”!
ngk<kqbI!fic!
Ofib<!fimz<!Ofib<!Lkz<!fimz<!kqvm<M–!Lkz<!higl<?!hg<gl<!.!276!
!
“OluqbuikR<!osb<Bl<!
G{f<kje!uqVl<hqg<OgT!
kiuqb!ubqX!lf<kR<sf<Kgiz<!ohiVk<K!Ofiuil<!
Osuqb!kiK!fisR<!
sqXk<Kme<!sqX!fQIuQPl<!
giuqbr<!g{<{qeiOt!
lzlK!gVgqg<!gi[l<”!
-vk<kqe!SVg<g!fic!
The above two poems describes that aggravation of Vatham naadi produces 
symptoms of Kalladaippu noi. 
“w{<{qb!uikolie<Xl<!hqk<klqv{<!omPf<kigqz<H{<o{e!
Bml<H!Ofiuil<!Hjgobp!obvqBl<!ofR<S!kq{<{lib<!
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fiuv{<M!sqXk<KfQIg<!gMk<K!uqPl<!n{<{uiI!
djvf<kU{<jl!biBV!Okue<kiOe”!
!
ke<uf<kqvq!juk<kqbl<!.!Lkz<!higl<?!hg<gl<!22!
The above line mentioned when Vatham and Pitham combined together which 
may result in Kalladaippu noi. 
2. Sparism (Touch) 
 In Sparism the temperature of skin (Thatpam-cold or veppam-heat),  
smoothness, roughness, sweating, dryness, hard patches, chillness, greasy, swelling 
abnormal growth of organs and tenderness can be felt. 
 On examination in Kalladaippu patients tenderness over the lower abdomen, 
renal angle and lumbar region can be felt, sometimes swelling can be felt (may be due 
to hydronephrosis) 
3. Naa (Tongue) 
 On examination the physician is expected to observe the features of the tongue 
and its colour, shape, size, coating, moisture, movement, ulcer, fissure, crust. In 
Kalladaippu noi, of the patient suffers from constipation, the tongue would seen to be 
coated. 
 In karuneer kalladaippu noi the patient has loss of taste sensation. 
! “gVfQi<gz<zqe<!utq!sqef<okPf<K!
! Sjuogmz<!outqX!lXh<H!fQi<Oum<jg”!
.Ofib<!uqtg<gl<!
4. Niram (Colour) 
            The physician is required to observe the colour of the skin, 
conjunctiva, tongue, nail bed and hair etc… and make a note if any abnormal colour 
changes. 
 Vali udal - black colour 
 Azhal udal - yellow or red colour 
 Iyya udal - white or yellow colour 
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 In Kalladaippu noi body complexion depends upon the body constitution, 
pallor of the body is observed in Sukkila ashmari. 
“sqg<gqfQi<!uqpi!lzr<Og!l{z<uqPl<!ouTg<Gf<Okgl<!
! lqg<G{R<!Sg<gqziS!liqbsik<!kqbole<OxiOki”!
ke<uf<kqiq!juk<kqbl<!.!3!higl<?!hg<gl<!21 
5. Mozhi (Speech) 
 By examining, the mozhi (speech) the vaious characters can be noted such as 
hoarseness, histery voice, slurring speech, various disorders of speech such as 
dysarthria can be noted. In kalladaippu noi, there is low pitch voice due to agonizing 
pain of lower abdomen and burning micturition. 
6. Vizhi (Eye) 
 On examine the colour of eye like pallour, reddish or yellowish discolouration 
and characters like dryness, odema, lacrimation any visual disturbances. 
7. Maalam (Stools) 
 It is necessary to examine the nature (consistency) colour, quantity, hard stools 
(or) loose stools presence of blood and froth and also pain during defecation. 
8. Moothiram (Urine) 
 Urine examination is one of the good diagnostic tool when compared to other 
Envagai thervugal. 
“kvqk<K!fihqg<G!SVg<glib<!Gx<xqs<!
szlzf<kie<!uQpilx<!xl<h!ligq!
uvqk<KOl!zqr<gk<kqz<!uzqB!ligq!
lVuqbOkiI!ohik<kqobziR<!Svf<K!gm<c!
kqiqk<kqOb!gqjmg<ogimih<!hqvm<mzigqk<!
Okl<hqOb!&s<Slib<!ubqX!Lh<Hl<!
dvqk<kOkiI!sjkOhiz!duIh<H!liGl<!
Yr<gqbOkiI!uikg<gz<z!jmh<H!kiOe”!
hi!83:?!hg<gl<!395!
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! In Kalladaippu Noi, urine was in high concentrate and sometimes it contains 
blood stains (Haematuria). Patient having loin to groin pain and burning pain with 
glans penis while passing urine or end of the urine. Sometimes patients having severe 
abdominal pain, urine is bitter taste or aromatic odour in nature. 
fQi<g<Gxqh<H!sqxh<H;Q < < < <Q < < < <Q < < < < !
“kIg<gsik<kq!kqvqg!tiOeiI!
kr<gtqx<!OxIf<K!fic!
uIg<glil<!fic!ke<eqz<!
uVuK!lbg<gl<!ole<Ox!
dx<xfQIh<!hvQj]!hib<f<Ok!
Bjvk<ke!iqkx<G!Ofvib<!
lx<oxiV!uqkqF~!zqz<jz!
lVk<Ku!gjzuz<OZiIg<Og”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!679!
 In order to sheet off the ambiguity in the diagnosis of disease through pulse 
perception. The exponent have charted out a method called Neerikuri – an in 
camparable method of diagnosis. 
sqXfQiqe<!ohiKG{l<!;Q < <Q < <Q < < !
! “uf<kfQVg<!giqobjm!l{l<!Fjv!wR<sOze<!
! jxf<kqb!ZTju!bjxGK!LjxOb”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!621!
 The above line mentioned that the five parameters should be examined in each 
urine sample. 
1. Niram (Colour) 
2. Edai (specific gravity) 
3. Nurai (froth) 
4. Naatram (smell) 
5. Enjal (Deposits) 
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a) Niram (colour) 
 Nira thogai: 
“hQkl<!osl<jljhr<!gVjl!ou{<jlobe<!
Oxikr<!ogiPjljb!obik<KG!fQOv!
sqk<k!lVk<Kuir<gs<!SVg<gl<!hg<gl<!621 
 The above poem reveals that urine colour as follows. 
1. Yellow,    2. Red,    3. Green,    4. Black,    5. White. 
gz<zjmh<H!fQiqe<G{l<!)< < Q < << < Q < << < Q < < Colour indicating urinary stone*!;!
“kQh<Hziz<!gPfQIs<!osbozeqx<!G{<cg<!
gib<k<KIh<!hzk<kiz<!gkqk<k!fQvilk<!
KIh<hzg<!ghLl<!OsiiqBl<!ogikqh<Hxh<!
hx<hg!zigh<!jhjbh<!hkqf<Ok”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!631!
 The colour of the urine look like decomposed flesh cleaned water indicates the 
presence of kidney stones. 
b) Edai (specific gravity) 
“lqgk<kch<!Hllqgk<!OkxZl<!-e<oxeqz<!
Sgk<jkk<!kVl<olb<s<!ShiufQI!fe<Ox”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!639!
Urine which is not thick it is considered to be healthy one. 
c) Nurai (Froth) 
“hf<kolb<h<!hjsbqt!gh<hMl<!hVuk<!
kf<kIh<!H,klib!fqzLk<!kqvk<kqz<!
sl<hf<kh<!hMl<!kkq!Fjvh<!HeOz”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!639!
In normal condition, urine is frothy in nature. When these is reduced froth in 
the urine it indicates derangement of vali, Azhal, Iyyam. 
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d) Naatram (smell) 
“gi{qkqz<!sQPl<!gzf<kqpq!l{Lxqe<!
gVh<hfi!hqgTTr<!gilfitk<KTl<!
uqv{Le<!ce<Oxe<!wb<Kl^<!lvqbz!
kqVk<kOz!kq{<{!olelek<!Ke<Oe”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!62:!
 The above poem states that foul colour with pyuria is observed in patient with 
urolithiasis is associated with secondary Urinary tract infection. 
e) Enjal (Deposits) 
“fiIk<kq!fQIhiz<!Ohiz!
fjuBx<xr<!gqpqB!lieiz<!
livx<h!Lx<x!fQvq!
zcl{<cg<!gqmf<f!kieiz<!
hivqf<k!olPG!lir<gib<!
hx<xqb!gz<zqeiOz!
sQVx<x!osb<jg!obe<X!
okvqUxosh<h!ziOl!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!686!
 The colour of the urine excreted looks like curd water or milk and the 
presence of white colour and sand like deposits in urine indicated stones in the 
kidney. 
2.1.22ofb<Gxq<<< !)GENERAL EXAMINATION) 
“nVf<Kli!xqvkLl<!nuqOvi!klkib<!
n0gz<!nzIkz<!ngizu,{<!kuqIf<kpx<!
Gx<xt!uVf<kq!dxr<gq!jugjx!
Ncg<!gzsk<!kiuqob!giKohb<!
okiVL%Ik<!kg<gjzg<!Gm<hM!fQvqe<!
fqxg<Gxq!ofb<Gxq!fqVlqk<kz<!gmOe”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!61:!
29 
 
Preparation of the patient:  
On the day before the urine examination for Neikuri, the patient should be 
advised to take balanced diet and quantity of food must be proportionate to his 
appetite. In addition he/she should have a good sleep. 
Method: 
 After waking up in the early morning, urine should be collected in a glass 
container and must be examined with in 1 ½ hours. Then a drop of gingely oil should 
be added through the side of the container without any disturbance. The nature of 
neikuri should be noted under direct sunlight. 
Observation : 
    Vatha Neer: 
“nvoue!fQ{<ce<!n0Ok!uikl<”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!643!
 In the drop of oil, lengthening like a snake it indicates vathaneer. 
Pitha Neer: 
“NpqOhix<!hvuqe<!n0Okhqk<kl<”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!644!
 In the drop of oil spreading like a ring, it indicates pitha neer. 
KabhaNeer: 
“Lk<okik<K!fqx<gqe<!olipq!uke<!ghOl”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!645!
! In the drop of oil, remaining as that of pearl, it indicates kapha neer. 
Thontha neer: 
“nvuqzizqBl<!Npqbqz<!<nvUL<!
nvuqe<Lk<Kl<!Npqbqz<!Lk<Kl<!
Okix<xqz<!okif<k!Okimr<gtiOl”!
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The thontha neer appears as a combination of the above pattern. 
Mukkutra neer: 
The drop of oil immersing in to the urine, indicates Mukkutraneer. 
sik<kqbl<?!nsik<kqbl<< < < << < < << < < < (PROGNOSIS) 
“$m<cm<m!sik<kqbk<jk!osiz<zg<!Ogtib<!
STg<giGl<!uiik<kqe<!gz<zjmh<H!
H,m<cm<m!hqk<kk<kqe<!gz<z!jmh<Hh<!
Hgpie!Osm<Mlk<kqe<!gz<z!jmh<H!
!
&m<cm<m!-K&e<X!lsik<b!ligq!
Ljebie!lVf<Kgtqx<!osl<jl!biGl<!
Okim<cm<m!okif<klir<!gz<z!jmh<Hk<!!
okiMSxOu!ogiz<ZlqK!$m<sf<!kiOe”!
!
B,gq!juk<kqb!sqf<kil{q!911!
 According to YUGI VAIDHIYA CHINTHAMANI-800 Vatha, Pitha, Kabha 
kalladaippu are  curable and preventable, but Mukkutra Kalladaippu is not curable. 
 According to ROGA NIRNAYA SAARAM under Rogam Nithanam, 
symptoms of kallaidaippu noi like scrotal swelling and anuria are not curable. 
 
2.1.12 LINE OF TREATMENT ADVOCATED AS PER THE SIDDHA 
PRINCIPLES: 
 In Urolithiasis, vatham and pitham are the two predominant factors which is 
responsible for the predisposition of stone formation, it is associated with heat and 
dryness. So the treatment should be planned towards the settlement of the affected 
humours as primary goal and secondary objective with medication towards the target 
action at specific sites and tertiary target to strengthen the system for the prevention 
of the disease. 
 As the above mentioned poem, purgation should be given to all patients as per 
their by condition. 
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kazhichal marunthu (purgatives) : Decoctions and mediated ghee with coolant 
properties are used to promote purgative to cleanse the colon bring about a balance of 
the impaired “TRIDHOSHAM”. 
2.1.13 DIET: 
 Diet plays an important role in both prevention and protection of the body 
from stone diseases. Diet can contribute to the actiology, management or prevention 
of recurrence of kidney stone, because dietary ingredients and fluid intake influence 
the volume, PH and solute concentration of urine. 
 In urolithiasis, the diet should on with the target to promote the urination, 
washout the urinary bladder and to expel the small stones. 
d{U!hpg<gupg<gr<gt<;< < < << < < << < < < !
d{<{g<%cbju;< << << < !
 GVju?!l{g<gk<jk!niqsq!bizig<gqb!OsiX!d{<{!Ou{<Ml</!
 hii<zq!niqsqg<gR<sq?!-tfQi<!nVf<kUl</!
 Lt<tr<gq?! uijpk<k{<M?! nujvg<gib<?! H,s{qg<gib<?! Sjvg<gib<?Ogvm<?!
ou{<jmg<gib<!Osi<g<g!Ou{<Ml</!
 ki<H,s{q?!hh<hitq?!ogib<bi?!wZlqs<js!Osi<g<gzil</!
 hsjzg<gQjv?!gisqeqg<gQjv?!gQjvk<k{<M?!out<tiq!uqjk!d{<{Ul</!
kuqi<g<g!Ou{<cju< < << < << < < ;!
 kg<gitq?!Lm<jmOgi^<?!gizqh<tui<?!dVjtgqpr<G?!gitie</!
 hiz<?!gihq?!C?!lKhiel<?!hkh<hMk<kh<hm<m!hier<gt<!nVf<kg<%miK/!
 Lm<jm?!J <^gqiQl<?!sig<Ozm<!kuqi<g<gUl</!
Advice :  
1. Patient should drink large quantity of water (4 litre/day)  
2. Patient should reduce salt intake 
3. Regarding prevention “Anubhava Vaidhya Deva ragasiyam” states the one 
should not suppress the excretion of moothiram (Urine) and sukkilam 
(Seminal fluid) is most predisposing cause for Kalladaippu noi. 
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2.2 MODERN ASPECT 
      2.2.1 URINARY SYSTEM 
 The urinary system also known as the renal system consists of the kidneys, 
ureters, urinary bladder, and urethera. The purpose of the urinary system to eliminate waste 
from the body, regulate blood volume and blood pressure, control levels of electrolytes and 
metabolites and regulate blood PH. Following filtration of blood and further processing, 
wastes (in the form of urine) exit the kidney via the ureters, tubes made of smooth muscle 
fibres that propel urine towards the urinary bladder, where it is stored and subsequently 
expelled from the body by urination (voiding) through urethera.  
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            2.2.2 UROLITHIASIS 
 Urolithiasis is the process of forming stones in the kidney, bladder, and or urethera. It 
is a solid concentration or crystal aggregation formed in the kidneys from dietary minerals in 
the urine. The common cause are blood in the urine and pain in the abdomen flank or groin 
region. The development of the stone is related to decreased urine volume or increased 
excretion of stone –forming components such as calcium, oxalate, urate, cystine, xanthine, 
and phosphate. It is estimated that approximately 2% of the population experiences renal 
stone disease at sometime in their life with male-female ratio of 2:1. The peak incidence is 
observes in 2nd and 3rd decades of life. 
 
              2.2.3 EPIDEMOLOGY: 
Hereditary: 
 Familial renal tubular acidosis are associated with nephrolithiasis in almost 70% of 
patients. Cystinuria, xanthinuria, are the disorders that causes renal stones. 15% of patients 
give a familial history of stone disease. 
Age: 
 The peak incidence of urinary calculus in the age of 20-40 years. 
Sex: 
 Males are mostly affected than females, because increased serum testosterone causes 
increased endogenous oxalate production in males. 
Geographical influence: 
 The prevalence of urinary calculi is higher in those who live in mountains, desert, and 
tropical areas. 
Climate and seasonal factors: 
 Incidence of urinary calculi and aggravation of symptoms are noted during summer 
months. 
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Water intake: 
 Urine dilution by increased water intake may increased ion activity coefficients and 
hence urinary crystallization, water diuresis reduces the average time of residence of free 
crystal particles in urine dilutes components of urine that may crystals. Minerals contents 
of water may contribute to cause stone disease, (E.g Sodium Chlorides) zinc in an inhibitor 
of calcium crystallization. 
Dehydration: 
 Not drinking enough water each day may increase risk of kidney stones people who 
live in warm climates and those who sweat a lot may be at higher risk than others. 
Diet: 
 High oxalate, high calcium and high uric acid diets may promote stone disease. 
Vitamin-A, pyridoxine and magnesium are thought to inhibit stone disease. 
PREDISPOSING FACTORS FOR URINARY STONES: 
       ENVIRONMENTAL AND DIETARY: 
 Low urine volumes: High body temperatures. 
       Low fluid intake. 
 Diet: High protein intake. 
 High calcium intake. 
 High sodium excretion.  
 High oxalate excretion. 
 Low citrate excretion. 
 
ACQUIRED CAUSES: 
 Hypercalcaemia of any cause. 
 Renal tubular acidosis type-1 
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CONGENITAL AND INHERITED CAUSES: 
 Familial hypercalciuria. 
 Medullary sponge kidney. 
 Primary hyperoxaluria. 
 Cystinuria. 
 
          2.2.4 AETIOLOGY 
1. CALCIUM STONES: 
Aetiology of calcium stones is variable. 
1. About 50% of patients with calcium stones have idiopathic hypercalciuria 
without hyper calcaemia. 
2. Approximately 10% cases are associated with hyper calcaemia and 
hypercalciuria, most commonly due to hyperparathyroidism, or a defect in 
the bowel ( i.e.,absorptive hypercalciuria), or in the kidney (i.e., renal 
hypercalciuria) 
3. About 15% of the patients with calcium stones have hyperuricosuria with 
a normal blood uric acid level and without any abnormality of calcium 
metabolism. 
4. In about 25% of patients with calcium stones, the cause is unknown as 
there is no abnormality in urinary excretion of calcium, uric acid or oxalate 
and is referred to as 'idiopathic calcium stone disease'. 
2. MIXED (STRUVITE) STONES: 
 Stuvite stones arre formed as a result of infection of the urinary tract with 
urea-splitting organisms that produce urease such as by species of Proteus, and 
occasionally Klebsiella,Pseudomonas and Enterobacter. These are, therefore, also 
known as infection-induced stones.However, E.coli does not form urease. 
3. URIC ACID STONES: 
 Uric acid stones are frequently formed in cases with hyperuricaemia and 
hyperuricosuria such as due to primary gout or secondary gout due to 
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myeloproliferative disorders (e.g. in leukaemias), especially those on chemotherapy, 
and administration of uricosuric drugs (e.g. salicylates, probenacid). Other factors 
contributing to their formation are acidic urine pH (below 6) and low urinary volume. 
4. CYSTINE STONES: 
Cystine stones are associated with cystinuria due to a genitically-determined 
defect in the transport of cystine and other amino acids across the cell membrane of 
renal tubules and the small intestinal mucosa. 
5. OTHER CALCULI: 
Are caused due to inherited abnormality of enzyme metabolism. 
   2.2.5 TYPES OF URINARY STONES:  
 There are four types of urinary calculi, they are 
1. Calcium type of stone-75% 
2. Mixed (struvite) type of stone-15% 
3. Uric acid type of stone-6% 
4. Cystine type of stone-2% 
5. other types-<2% 
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1. CALCIUM STONES: 
Most kidney stones are made up of calcium compounds, especially calcium 
oxalate. Calcium stones are the most common comprising about 75% of all urinary 
calculi. They may be pure stones of calcium oxalate (50%) or calcium phosphate (5%) 
or a mixture of calcium oxalate and calcium phosphate (45%).Calcium stones are 
usually small (4-5mm), ovoid, hard, with granular rough surface. They are dark brown 
due to old blood pigment deposited in them and as a result of repeated trauma caused 
to the urinary tract by these sharp-edged stones. High levels of oxalate also increase in 
the risk for calcium stones. 
2. MIXED (STRUVITE ) STONES: 
About 15% of urinary calculi are made of magnesium-ammonium-calcium 
phosphate, often called struvite, hence mixed stones are also called as struvite stones' 
or' triple phosphate stones. 
Struvite stones are yellow-white or grey. They tend to be soft and friable and 
irregular in shape. 'Staghorn stone' which is large, solitary stone that takes the shape 
of the renal pelvis where it is often formed is an example of struvite stone. 
They can also be called infection stones if they occur with kidney or urinary 
tract infections. These types of kidney stones sometimes are also called staghorn 
calculi if they grow large enough. 
3. URIC ACID STONES: 
Approximately 6% of urinary calculi are made of uric acid. Uric acid stones 
are adiolucent unlike radio-opaque calcium stones. Uric acid stones are smooth, 
yellowish-brown, hard and often multiple. On cut section, they show laminated 
structure. 
You are more likely to have uric acid stones if u have: 
•
 Low urine output. 
•
 A diet high in animal protein, such as red meat. 
•
 An increase in how much alcohol you drink. 
•
 Gout 
•
 Inflammatory bowel disease. 
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4. CYSTINE STONES: 
Cystine stones comprise less than 2% of urinary calculi. Cystine stones are 
small, rounded, smooth and often multiple. They are yellowish and waxy. They occur 
in both men and women who have the genetic disorder cystinuria. 
5. OTHER CALCULI: 
Less than 2% of urinary calculi consist of other rare types such as Xanthine 
stones. 
This tabular column represented with prevalence of various stones and its colours 
Kidney 
stone type 
Population Circumstan
ces 
Color  
Sensitivity 
 
Details 
 
Calcium 
oxalate 
 
80% 
 
When urine 
is acidic 
(decreases 
PH) 
 
Black/dark 
brown 
 
Radio 
opaque 
Some of the oxalate in urine is 
produced by the body.  
Calcium and oxalate in the diet 
play a part but are not the only 
factors that affect the formation 
of calcium  
Calcium 
phosphate 
 
5-10% 
When urine 
is alkaline 
(high PH) 
Dirty white Radio 
opaque 
Tends to grow in alkaline urine 
especially when proteus are 
present. 
 
Uric acid 
 
5-10% 
 
When urine 
is 
persistently 
acidic. 
 
Yellow 
reddish 
brown 
 
Radiolucen
t 
Diets rich in animal proteins 
and purines: substances found 
naturally in all food but 
especially in organ meats, fish, 
and shellfish.  
 
Struvite 
 
10-15% 
 
Infection in 
the Kidney 
 
Dirty white 
 
Radio 
opaque 
Preventing struvite stones 
depends on staying infection-
free.  Diet has not been shown 
to affect struvite stone 
formation. 
 
Cystine 
 
1-2% 
 
Rare genetic 
disorder 
 
Pink/yellow 
 
Radio 
opaque 
Cysteine, an amino acid (one of 
the building blocks of protein) 
leaks through the kidneys and 
into the urine to from crystals. 
 
Xanthine 
  
Extremely 
 
Brick red 
Radio 
opaque 
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2.2.6 PATHOGENESIS OF STONES 
Urinary stones usually arise because of the breakdown of a delicate balance between 
solubility and precipitation of salts. The kidneys must conserve water, but they must excrete 
materials that have a low solubility. These two opposing requirements must be balanced 
during adaptation to diet, climate, and activity. The problem is mitigated to some extent by 
the fact that urine contains substances that inhibit crystallization. These protective 
mechanisms are less than perfect. When the urine becomes supersaturated with insoluble 
materials, because excretion rates are excessive and/or because water conservation is 
extreme, crystals form and may grow and aggregate to form a stone. 
SUPERSATURATION: 
A solution in equilibrium with crystals of calcium oxalate is said to be saturated with 
respect to calcium oxalate. If crystals are removed, and if either calcium or oxalate ions are 
added to the solution, the chemical activities increase, but no new crystals form. Such a 
solution is metastably supersaturated. If calcium oxalate crystals are now added, they will 
grow in size. Ultimately, as calcium or oxalate is added to the solution, supersaturation 
reaches a critical value at which a solid phase begins to develop spontaneously. This value is 
called the upper limit of metastability. Kidney stone growth requires a urine that, on average, 
is supersaturated. Excessive supersaturation is common in stone formation. 
Calcium, oxalate, and phosphate form many soluble complexes among themselves 
and with other substances in urine, such as citrate. As a result, their free ion activities are 
below their chemical concentrations. Reduction in ligands such as citrate can increase ion 
activity and, therefore, supersaturation. Urine supersaturation can be increased by 
dehydration or by overexcretion of calcium, oxalate, phosphate, cystine, or uric acid. Urine 
pH is also important; phosphate and uric acid are acids that dissociate readily over the 
physiologic range of urine pH. Alkaline urine contains more dibasic phosphate, favoring 
deposits of brushite and apatite. Below a urine pH of 5.5, uric acid crystals (pK 5.47) 
predominate, whereas phosphate crystals are rare. The solubility of calcium oxalate is not 
influenced by changes in urine pH. Measurements of supersaturation in a 24-h urine sample 
probably underestimate the risk of precipitation. Transient, dehydration, variation of urine 
pH, and postprandial bursts of over excretion may cause values considerably above average. 
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CRYSTALLIZATION: 
When urine supersaturation exceeds the upper limit of metastability, crystals begin to 
nucleate. Cell debris and other crystals present in the urinary tract can serve as templates for 
crystal formation, a process known as heterogeneous nucleation. Heterogeneous nucleation 
lowers the level of supersaturation required for crystal formation. Once formed, crystal nuclei 
will grow in size if urine is supersaturated with respect to that crystal phase. Multiple crystals 
can then aggregate to form a kidney stone. 
In order for a kidney stone to form, crystals must be retained in the renal pelvis long 
enough to grow and aggregate to a clinically significant size. The mechanism of crystal 
retention has been a matter of much debate. Recent studies have shown that common calcium 
oxalate kidney stones form as overgrowths on apatite plaques in the renal papillae. These 
plaques, called Randall's plaques, provide an excellent surface for heterogeneous nucleation 
of calcium oxalate salts. The Randall's plaques begin in the deep medulla in the basement 
membrane of the thin limb of the loop of Henle and then spread through the interstitium to 
the basement membrane of the papillary urothelium. If the urothelium becomes damaged, the 
plaque is exposed to the urine, and calcium oxalate crystallization and stone formation 
begins. 
INHIBITORS OF CRYSTAL FORMATION: 
Urine contains potent inhibitors of nucleation, growth, and aggregation for calcium 
salts. Inorganic pyrophosphate is a potent inhibitor that appears to affect formation of 
calcium phosphate more than calcium oxalate crystals. Citrate inhibits crystal growth and 
nucleation, although most of the stone inhibitory activity of citrate is due to lowering urine 
supersaturation via complexation of calcium. Other urine components such as glycoproteins 
inhibit calcium oxalate crystallization. 
1. CALCIUM STONES: 
The mechanism of calcium stone formation is explained on the basis of imbalance 
between the degree of super saturation of the ions forming the stone and the concentration of 
inhibitors in the urine. Most likely site where the crystals of calcium oxalate and/or calcium 
phosphate are precipitated is the tubular lining or around some fragment of debris in the 
tubule acting as nidus of the stone. The stone grows, as more and more crystals are deposited 
around the nidus. A number of other predisposing factors contributing to formation of 
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calcium stones are alkaline urinary pH, decreased urinary volume and increased excretion of 
oxalate and uric acid. 
2. MIXED (STRUVITE) STONES: 
Struvite stones are formed as a result of infection of the urinary tract with urea-
splitting organisms that produce urease. 
3. URIC ACID STONES: 
The solubility of uric acid at pH of 7 is 200 mg/dl while at pH of 5 is 15 mg/dl. Thus, 
as the urine becomes more acidic, the solubility of uric acid in urine decreases and 
precipitation of uric acid crystals increases favouring the formation of uric acid stones. 
Hyperuricosuria is the most important factor in the production of uric acid stones, while 
hyperuricaemia is found in about half the cases. 
4. CYSTINE STONES: 
The resultant excessive excretion of cystine which is least soluble of the naturally 
occurring amino acids leads to formation of crystals and eventually cystine calculi. 
 
2.2.7 CLINICAL SYMPTOMS:        
• Haematuria. 
• Recurrent urinary tract infection. 
• Painful urination. 
• Sweating. 
 Renal colic pain typically comes in waves lasting for 20-30 minutes, beginning in the 
flank or lower back and often radiating to the groin region or genitalis. 
 Kidney stone symptoms:  
Stones in the kidney can become lodged at the junction of kidney and ureter 
(uretero pelvic junction), resulting in 
• Severe colicky flank pain, pain can be localized at the costo 
vertebral angle. 
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• Haematuria may be present intermittently or persistently. 
 Uretheral stone symptoms:       
 Stones that can pass into the ureter, it produce 
• Acute, sharp spasm with intermittent colicky pain radiating to the 
lateral flank and around the umbilical region. 
• Haematuria. 
• As a stone passes through the distal ureter near the bladder. 
• Nausea and vomiting. 
 Bladder stone symptoms: 
Once a stone enters the bladder 
• Dysuria and urgency and frequency of micturition may be the only 
symptoms experienced. 
• Immediate relief of symptoms occurs once the stone passes out of 
bladder. 
 
2.2.8 DIAGNOSIS: 
 The diagnosis of kidney stones on the basis of, information obtained from history and 
physical examination. 
Other tests: 
 Complete blood count (CBC), looking for neutrophilia, (increased 
neutrophil granulocyte count) suggestive of bacterial infection, as seen 
in setting of struvite stones. 
 Blood tests for calcium, phosphorus, uric acid, and electrolytes. 
 Blood urea nitrogen (BUN) and creatinine to assess kidney 
functioning. 
 Urine analysis- microscopic examination of the urine, which show 
• Red blood cells. 
• Epithelial cells. 
• Urinary casts and crystals. 
• Pus cells. 
 Abdomen x-rays. 
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 Ultra sound examination of the kidney. 
 Intra venous pyelogram. 
 Retrograde pyelogram. 
 MRI of the abdomen and kidneys. 
 Abdomen CT scan. 
 Stone analysis is done of collected stones can establish their 
composition, which in turn can help future preventive and therapeutic 
management. 
2.2.9 DIFFERENTIAL DIAGNOSIS: 
 Appendicitis. 
 Cholecystitis and cholelithiasis. 
 Ectopic pregnancy and pelvic inflammatory disease. 
 Pancreatitis. 
 Gastric and duodenal ulcers. 
 Pyelonephritis. 
 Diverticulis. 
2.2.10 COMPLICATIONS: 
 Occassionally, stones can injured the kidneys by causing infectio, resulting in 
 Recurrent UTI. 
  Pyelonephritis. 
 Obstructive Uropathy.  
 Hydronephrosis. 
 Acute or Chronic Renal Failure. 
   2.2.11 MEDICATION:                 
 LITHOTRIPSY: 
Extra corporeal shock wave lithotripsy uses sound waves to breakup large 
stones, so they can more easily pass down the ureters into your bladder. 
This procedure can be uncomfortable and may require light anaesthesia. 
 URETEROSCOPY: 
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When a stone is stuck in the ureter or bladder. your doctor may use an 
instrument called a ureteroscope to remove it. A small wire with a camera 
attached is inserted into the urethra and passed into the bladder. A small 
cage is used to snag the stone and remove it. The stone will be sent to 
analysis. 
2.2.12 DIET FOR URINARY STONES:  
 CALCIUM STONES: 
• A diet that increase blood and urine levels of calcium, 
such as caffeine and sodium. 
• Coffee, chocolate, cool drinks, must be avoided. 
• Vitamin B6 is to reduce the urinary calcium levels. 
• Oxalate rich foods like spinach, beet, black tea, and 
nute are also avoided. 
• Also avoid vitamin C rich foods, because it converts to 
oxalate, oxalate excreted in urine. 
 STRUVITE  STONES: 
• They modify their diet to increase the acidity of urine 
to inhibit bacterial growth. Urine acidifiers include 
specific tablets, animal proteins, and citrus fruits. 
 URIC ACID STONES: 
• Avoid animal sources of protein. 
• Even vegetable sources of protein like pulses and 
grains are also restricted. 
 CYSTINE STONES: 
• Avoid fish and grains containing protein. 
• The food which help to raise the PH of the urine such 
as vegetable juices and fruits can be taken. 
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CHAPTER-III 
MATERIALS AND METHODS 
 
3.1 STUDY DESIGNS AND CONDUCT OF THE STUDY: 
 A Prospective open labeled randomized clinical trial on 
“KALLADAIPPU” was carried out in the Post Graduate Department Of Pothu Maruthuvam 
from the study period of AUGUST 2017-JUNE2018 at Government Siddha Medical College 
and Hospital, Palayamkottai-6270O2. Tirunelveli, Tamilnadu. 
 The study was approved by Institutional Ethics Committee (IEC) 
(IEC, GSMC/3-IEC/2016-I-7/20.07.2016) 
 The study was registered in Clinical Trials Registry-India (CTRI) and 
the reference number is 2017/08//009576- AUGUST 31 
 The study was approved by Institutional Animal Ethics Committee 
(IAEC), SASTRA University held on 09.09.2017. CPCSEA approval number : 
483/SASTRA/IAEC/RPP. 
 
3.2 SAMPLE DESIGN: 
 Totally 40 patients were selected in Kalladaippu Noi, among 40 (20-Outpatients 
and 20-Inpatients) of both sexes between age groups of 20-60 years, were recruited for study 
and treated with the trial drug till the end of the study period.  
 
3.3 CRITERIA FOR THE SELECTION OF PATIENTS: 
 For the present study, patients were selected based on the following criteria 
 Ultra sonogram report, indicating the presence of renal calculus. 
 Urine analysis report, indicating the presence of crystals, albumin and 
RBCS deposition in the urine. 
                             Clinical history of patients with the following  symptoms                                                                                      
 Renal colicky pain, Burning micturition, Oliguria, Haematuria, 
Nausea and Vomiting. 
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3.4 COLLECTION AND MAINTENANCE OF PATIENT’S DATABASE: 
 A proforma was prepared to collect details about the patients personal and 
family history, present symptoms, history of recent and past illness, laboratory investigations  
(including urine and blood analysis). Ultra sonogram, method adopted for the purpose of 
treatment and management of the disease and follow-up procedures. The details collected 
were recorded in proforma for each individual patient and database was maintained for all the 
patients. 
 
3.5 SELECTION OF TRIAL MEDICINE: 
 The trial medicine, SIRU NERUNJIL KUDINEER (Internal) is selected based 
on their medicinal values in treating KALLADAIPPU NOI, mentioned in the Siddha 
literature GUNAPAADAM MOOLIGAI Page.no. 597. 
 The ingredient was collected, purified properly and prepared according to the 
literature. The drug is given to the patients for the entire course of treatment. References are 
enclosed in ANNEXURE-I 
 3.5.1 Pre Clinical Analysis of Trial Medicine:  
                         All the pre clinical studies of my trial drug  had included Bio chemical 
analysis, Physio-chemical analysis, Acute toxicity studies and Pharmacological studies has 
done and cross checked before beginning the trial. 
A) Biochemical Analysis of the trial medicine: 
 Biochemical analysis of the trial medicine was performed at the 
Biochemistry unit of Government Siddha Medical College and Hospital, Palayamkottai. 
Experiments were conducted by the unit by following the standard procedures to known the 
presence of minerals. The results of the Biochemical Analysis and Inferences are given in 
ANNEXURE-II 
B) Physiochemical Analysis of the trial medicine: 
 It was performed at the Chennai testing laboratory private limited, 
Chennai. Experiments were conducted by the unit by following standard procedures to 
known the presence of minerals and microbiology. The results of the physiochemical analysis 
and results are given in ANNEXURE-III 
C) Acute Toxicity studies of the trial medicine: 
 Acute toxicity study for my trial drug was already done by 
DR.SUDHAHAR M.D(S) studied in Govt. Siddha Medical College, Palayamkottai. at the 
academic year of OCTOBER 2013 - OCTOBER2016. The study proposal number is 
PCP/IAEC/013/2015. was done at Periyar College Of Pharmaceutical Sciences, Trichy.  
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D) Pharmacological Analysis of the trial medicine:  
 Pharmacological actions of the trial medicine were studied at SASTRA 
University, Thanjavur. Experiments were conducted with albino rats by following the 
standard procedures to determine the Pharmacological actions like Lithotriptic effect. The 
procedure, results and inferences are given in ANNEXURE-IV 
 
E) Microbial studies of the trial medicine: 
  Microbial study for my trial drug was done at Malar Diagnostic Centre, 
Tirunelveli. The results of Microbial analysis and results are given in ANNEXURE-V 
 
3.6 INVESTIGATIONS: 
 The patients were subjected to the following investigations to establish the 
diagnosis. The investigations were carried out regularly before and after the treatment. 
• Routine laboratory investigations such as blood examination was 
tested biochemically to known the present functional status of the 
body and also urine tests was tested to known any depositions and 
other pathological constitutents. 
• All the patients were subjected to USG Abdomen before and after 
the treatment. The USG reports of few patients are enclosed in 
ANNEXURE-VI 
• During the course of treatment the expulsion of stones were 
analysed in a well reputed medical laboratory to determine the type 
of stones. The stone analysis reports are given ANNEXURE-VI. 
 
3.7 OUTCOME OF THE STUDY: 
                   The outcome of the study was measured by complete reduction of clinical 
symptoms and clearance /reduction in the size of renal calculus by conform USG-Abdomen,  
using the following Urolithiasis symptoms score. The score of each case at the time of 
enrolment and at the end of treatment were compared and on its basis the patient was 
informed that he/she was symptoms free and cured. 
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Urolithiasis Symptom Score: 
(Circle relevant number on each line) 
 
1. Pain/colic 0- No pain 1- Mild pain 
2 -Moderate 3- Severe 
pain pain    
2. Haematuria 0 –No 1- Microscopic 2- Persistent 3 -Gross 
 Haematuria    
     
3. Dysuria 0 -No dysuria 1- Mild dysuria 2- Moderate 3- Severe 
   dysuria  
     
4. Stone  1- Single stone 2- Multiple  
   stone  
     
5. Size of 0- Gravel < 1-3 mm to < 4 2-4 mm to < 3-5 mm and 
Stones 03mm mm 5 mm above 
     
6. Position of 0- no stone in 1-Pelvic ureteric 2- Pelvis of 3 Calyces of 
stone in Kidney junction kidney kidney 
Kidney     
     
7. Position of 0- no stone in 1- Lower part of 2- Middle of 3- Upper 
stone in ureter Ureter ureter ureter part of 
    Ureter 
     
8. Position of 0 -no stone in 1 -Base of 2- Intramural  
stone in Bladder bladder ureter  
Bladder     
     
 
 
Total scoring – 22, 1-7 mild, 8-14 moderate, 15-22 severe. 
Symptoms score – (Some of 8 circled numbers) 
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CHAPTER IV 
OBSERVATION AND RESULTS 
 The results obtained from the presence study were recorded in the proforma with 
respect to the following parameters for each patient both out-patients and in-patients. They 
were analysed statistically in order to arrive at the percentage composition. 
1. Age (Kaalam) Distribution 
2. Gender Distribution 
3. Occupational Status 
4. Dietary Habits 
5. Marital Status 
6. Personal Habits 
7. Paruvakaalam (Season) 
8. Thinai (Land) 
9. Thegathathuvam (Thegi) 
10. Manothathuvam (Gunam) 
11. Uyir Thathukal 
a) Derangement of Vatham 
b) Derangement of Pitham 
c) Derangement of Kabam 
12. Udal Thathukal 
13. Kosangal 
14. 14 Vegangal 
15. Envagai Thervugal 
16. Neerkuri 
17. Neikuri 
18. Duration of Illness 
19. Number of Stones 
20. Position of Stones 
21. Size of Stones 
22. Urolithiasis Symptoms Score 
23. Grading outcomes of the study 
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Table 1 : AGE DISTRIBUTION 
            
sl 
no 
Age 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Vatha kaalam  (0-33 years) 8 40% 6 30% 
2 Pitha kaalam  (34-66 years) 12 60% 14 70% 
3 Kabha kaalam (67-100 years) 0 0% 0 0% 
 
Figure 1 : AGE DISTRIBUTION 
 
 
Inference: 
             The above table reveals that majority of both out patients 60% and in patients70%  
comes under Pitha kaalam,  40% of outpatients and 30% of inpatients  comes under  Vatha 
kaalam.  
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Table 2 : GENDER DISTRIBUTION 
            
sl no Gender 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Male 10 50% 13 65% 
2 Female 10 50% 7 35% 
 
Figure 2 : GENDER DISTRIBUTION 
 
 
Inference: 
             From the above table, out patients (50%) of both Male and Female were equally 
affected. And inpatients 65% were Male and 35% were Female affected. 
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Table 3 : OCCUPATIONAL STATUS 
            
sl 
no 
Occupation 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 House Wife 6 30% 4 20% 
2 Standing work 
style 4 20% 5 25% 
3 Sedentary work 
style 3 15% 6 30% 
4 Student 4 20% 2 10% 
5 Retired person 0 0% 2 10% 
6 Driver 2 10% 1 5% 
7 Farmer 1 5% 0 0% 
 
Figure 3 : OCCUPATIONAL STATUS 
 
Inference: 
           Among out patients majority of them are House Wives 30%, compared to otheir 
Works. Among in patients majority of them are Sedentary Workers 30%, compared to other 
Works. 
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Table 4 : DIETARY HABITS 
            
sl no Diet 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Vegetarian 3 18% 4 20% 
2 
Vegetarian & 
Non 
Vegetarian 
17 85% 16 80% 
 
Figure 4 : DIETARY HABITS 
 
 
Inference: 
                  This table reveals that majority of out patients 85% and in patients 80%, were 
both Vegetarian and Non- Vegetarian, compared to pure Vegetarian. 
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Table 5 : MARITAL STATUS 
            
sl no Marital 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Married 15 75% 17 85% 
2 Unmarried 5 25% 3 15% 
 
Figure 5 : MARITAL STATUS 
 
 
Inference: 
         This table reveals that majority of cases in out patients 75% and in patients 85% were 
Married, compared to Unmarried. 
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Table 6 : PERSONAL HABITS 
            
sl no Habits 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Alcohol 1 5% 1 5% 
2 Smoking 2 10% 2 10% 
3 Alcohol with 
smoking 2 10% 3 15% 
4 Tobacco / Betel chewing 0 0% 2 10% 
5 No Bad Habits 15 75% 12 60% 
 
Figure 6 : PERSONAL HABITS 
 
 
Inference: 
                   This table reveals that majority of them out patients 75% and in patients 60% 
does not have Bad Habits, compared to other Bad Habits.  
 
56 
 
 
Table 7 : PARUVAKAALAM (SEASON) 
            
sl 
no 
Paruvakaalam 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Kaarkaalam 5 25% 2 10% 
2 Koothirkaalam 2 10% 5 25% 
3 Munpanikaalam 1 5% 1 5% 
4 Pinpanikaalam 4 20% 6 30% 
5 Ilavenil 6 30% 6 30% 
6 Mudhuvenil 2 10% 0 0% 
 
Figure 7 : PARUVAKAALAM (SEASON) 
 
 
Inference: 
              Among out patients,majority of them  were Ilavenil Kaalam30%. And  in patients, 
majority of them were Ilavenil Kaalam 30% and also Pinpani Kaalam 30%. 
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Table 8 : THINAI (LAND) 
            
sl no Thinai 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Kurunji (Hill) 0 0% 0 0% 
2 Mullai (Forest) 0 0% 0 0% 
3 Marutham (Fertile) 13 65% 16 80% 
4 Neithal (Coastal) 7 35% 4 20% 
5 Pallai (Desert) 0 0% 0 0% 
 
Figure 8 : THINAI (LAND) 
 
 
Inference: 
          Among out patients, 65% were Marutham, 35% were Neithal. 
          Among in patients, 80% were Marutham, 20% were Neithal. 
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Table 9 : THEGA THATHUVAM 
            
sl no Thegi 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Vatha 12 60% 13 65% 
2 Pitha 6 30% 4 20% 
3 Kabha 2 10% 3 15% 
 
Figure 9 : THEGA THATHUVAM 
 
 
Inference: 
               Among out patients, 60% were Vatha Thegi, 30% were Pitha Thegi, 10% were 
Kabha Thegi. 
               Among in patients, 65% were Vatha Thegi, 20% were Pitha Thegi, 15% were 
Kabha Thegi. 
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Table 10 : MANO THATHUVAM (GUNAM) 
            
sl 
no 
Gunam 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Sathuvagunam 3 15% 3 15% 
2 Rajogunam 16 80% 14 70% 
3 Thamogunam 1 5% 3 15% 
 
Figure 10 : MANO THATHUVAM (GUNAM) 
 
 
Inference:  
           Among out patients, 80% were Rajogunam, 15% were Sathuvagunam,  5% were 
Thamogunam. 
           Among in patients, 70% were Rajogunam, 15% were Sathuvagunam, 15% were 
Thamogunam. 
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Table 11 : UYIR THATHUKAL  
A) Derangement of Vatham 
            
sl 
no 
Vatham 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Pranan 1 5% 2 10% 
2 Abanan 20 100% 20 100% 
3 Viyanan 0 0% 0 0% 
4 Uthanan 0 0% 0 0% 
5 Samanan 20 100% 20 100% 
6 Nagan 2 10% 4 20% 
7 Koorman 0 0% 5 25% 
8 Kirugaran 0 0% 0 0% 
9 Thevathathan 2 10% 3 15% 
10 Thanajeyan 0 0% 0 0% 
 
Figure 11 A : Derangement of Vatham 
 
Inference: 
    This table reveals that all the out patients and in patients have Derangement in Abanan and 
Samanan Vayus 100% were affected, compared to other Vayus. 
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Table 11 : UYIR THATHUKAL 
B) Derangement of Pitham 
            
sl 
no 
Pitham 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Analapitham 0 0% 0 0% 
2 Ranjagapitham 1 5% 3 15% 
3 Sathagapitham 16 80% 12 60% 
4 Prasagapitham 0 0% 0 0% 
5 Alosagapitham 0 0% 0 0% 
 
Figure 11 B : Derangement of Pitham 
 
 
Inference:  
             This table reveals that majority of the out patients 80% and in patients 60% were 
affected in Sathagapitham. And few cases affected Ranjagapitham. 
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Table 11 : UYIR THATHUKAL 
C) Derangement of Kabam 
            
sl 
no 
Kabam 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Avalambagam 0 0% 1 5% 
2 Kilethagam 0 0% 0 0% 
3 Pothagam 0 0% 0 0% 
4 Tharpagam 0 0% 0 0% 
5 Santhigam 1 5% 3 15% 
 
Figure 11 C : Derangement of Kabam 
 
Inference: 
          This table reveals that majority of out patients  5% and in patients 15% was affected 
Santhigam. And few patients were affected Avalambagam. 
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Table 12 : UDAL THATHUKAL 
            
sl 
no 
Udal Thathukal 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Saaram 10 50% 6 30% 
2 Seneer 3 15% 6 30% 
3 Oon 0 0% 0 0% 
4 Kozhuppu 0 0% 0 0% 
5 Enbu 2 10% 6 30% 
6 Moolai 8 40% 6 30% 
7 Sukkilam / Suronitham 0 0% 0 0% 
 
Figure 12 : UDAL THATHUKAL 
 
Inference: 
This table reveals that majority of the out patients 50% and in patients 30% were 
affected by Saaram. And few cases were also affected by Moolai, Enbu, Seneer. 
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Table 13 : KOSANGAL 
            
sl 
no 
Kosangal 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Annamayakosam 20 100% 20 100% 
2 Pranamayakosam 1 5% 2 10% 
3 Manomayakosam 0 0% 0 0% 
4 Vignamayakosam 0 0% 0 0% 
5 Anandamayakosam 0 0% 0 0% 
 
Figure 13 : KOSANGAL 
 
 
Inference: 
                 This table reveals that majority of the out patients 100% and in patients 100% were 
affected by Annamayakosam. And few cases were affected by Pranamayakosam. 
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Table 14 : 14 VEGANGAL 
            
sl no Vegangal 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Thummal 2 10% 3 15% 
2 Siruneer 20 100% 20 100% 
 
Figure 14 : 14 VEGANGAL 
 
 
Inference: 
             This table reveals that majority of the out patients 100%  and in patients  100% were 
affected by Siruneer. Few cases were affected by Thummal. And other vegangal were not 
affected. 
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Table 15 : ENVAGAI THERVUGAL 
            
sl no Envagai Thervugal 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Naa 1 5% 3 15% 
2 Niram 0 0% 0 0% 
3 Mozhi 0 0% 0 0% 
4 Vizhi 0 0% 5 25% 
5 Malam 0 0% 0 0% 
6 Moothiram 20 100% 20 100% 
7 Sparism 0 0% 0 0% 
8 Naadi 
    
  a) Vathapitham 12 60% 10 50% 
  b) Vathakabam 1 5% 1 5% 
  c) Pithavatham 7 35% 8 40% 
  d) Pithakabam 0 0% 1 5% 
  e) Kathavatham 0 0% 0 0% 
  f) Kabhapitham 0 0% 0 0% 
 
Figure 15 : ENVAGAI THERVUGAL 
 
Inference: 
          This table understood that majority of the out patients 100% and in patients 100% that  
Moothiram was  affected. And majority of cases Vathapitham  naadi was mostly observed. 
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Table 16 : NEERKURI 
              
sl no Type of Test Result 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Niram (Color) 
Normal 3 15% 2 10% 
Yellowish 13 65% 15 75% 
Yellowish 
Red 2 10% 1 5% 
2 Edai (Specific Gravity) 
Normal 0 0% 0 0% 
Affected 20 100% 20 100% 
3 Manam (Smell) 
Normal 0 0% 0 0% 
Affected 0 0% 0 0% 
4 Nurai (Froth) 
Normal 0 0% 0 0% 
Affected 0 0% 0 0% 
5 Enjal (Deposits) 
Absent 0 0% 0 0% 
Present 8 40% 6 30% 
 
Figure 16 : NEERKURI 
 
Inference: 
               Majority of patients have Yellowish Urine. All patients 100%  were affected by 
Edai  i.e Specific gravity. Enjal are also present in few patients. 
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Table 17 : NEIKURI 
            
sl no Neikuri 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Vathaneer 9 45% 8 40% 
2 Pithaneer 6 30% 9 45% 
3 Kaphaneer 5 25% 3 15% 
 
Figure 17 : NEIKURI 
 
 
Inference: 
             Majority of the patients, have  Vatha Neer (45% out patients and 40% in patients), 
and then Pitha Neer (30% out patients and 45% in patients), and also in few patients  Kabha 
neer  found. 
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Table 18 : DURATION OF ILLNESS 
            
sl no Duration 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Less than 8 
weeks 4 20% 5 25% 
2 2 - 6 months 7 35% 8 40% 
3 6 - 12 months 6 30% 4 20% 
4 1 - 1 1/2 years 3 15% 3 15% 
 
Figure 18 : DURATION OF ILLNESS 
 
 
Inference: 
           During  the time of period 2-6 months and 6-12 months have majority of out patients. 
During the time of period 2-6 m0nths and less than 8 weeks have majority of in patients. 
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Table 19 : NUMBER OF STONES 
  
sl 
no 
No. of 
Stones 
Before Treatment After Treatment 
Out patients In patients Out patients In patients 
No of 
Cases 
Percen
tage 
No of 
Cases 
Percen
tage 
No of 
Cases 
Percen
tage 
No of 
Cases 
Percen
tage 
1 Single 12 60% 14 70% 10 50% 11 55% 
2 Multiple 8 40% 6 30% 4 20% 4 20% 
 
Figure 19 : NUMBER OF STONES 
 
 
Inference: 
              This table reveals,  before treatment majority of the(60% out and 70% in patients)  
has Single stone, and few cases has Multiple stones. But after treatment (50% out and 55% in 
patients) were Single stone, and few were Multiple stones. 
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Table 20 : POSITION OF STONES IN URINARY SYSTEM 
            
sl no Position of Stones 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Both Kidneys 4 20% 3 15% 
2 Right Kidney 6 30% 7 35% 
3 Left Kidney 8 40% 9 45% 
4 Right Ureter 0 0% 0 0% 
5 Left Ureter 2 10% 1 5% 
 
Figure 20 : POSITION OF STONES IN URINARY SYSTEM 
 
Inference: 
               Majority of cases of out patients 40% has calculi in Left Kidney . And also in 
patients 45% has calculi in Left Kidney. 
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Table 21 : SIZE OF STONES  
 
sl 
no 
Size of 
Stones 
Before Treatment After Treatment  
Out patients In patients Out patients In patients P value 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percen
tage 
 
1  Above 5mm  11 55% 13 65% 2 10% 3 15% 
<0.00
01 
2 4 - 5 
mm 
6 30% 4 20% 6 30% 7 35% 
3 1 – 3 
mm 
3 15% 3 15% 6 30% 5 25% 
4 nil 0 0% 0 0% 6 30% 5 25% 
 
 
Figure 21 : SIZE OF STONES 
 
Inference: 
          Before treatment,  the USG reports of majority of cases, stone size will be 5mm and 
above , and  4mm to <5mm in second major cases. After treatment majority of the cases, 
stone size will be upto <3mm. Thus the drug will be reduce the stone size.  P<0.0001 was 
considered statistically significant difference. 
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Table 22 : UROLITHIASIS SYMPTOMS SCORE  
 
 
sl 
no 
Types of 
score 
Before After  
Out patients In patients Out patients In patients P value 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Pe
rce
nta
ge 
No 
of 
Case
s 
Perce
ntage  
1 15 - 22 (severe) 5 25% 7 35% 0 0% 0 0% 
<0.0001 
2 
8 - 14 
(moderat
e) 
15 75% 13 65% 3 15% 5 25% 
3 1 - 7 (mild) 0 0% 0 0% 11 
55
% 10 50% 
4 
No 
Sympto
ms 
0 0% 0 0% 6 30% 5 25% 
 
 
Figure 22 : UROLITHIASIS SYMPTOMS SCORE 
 
Inference: 
         The above table resembles that the score will be severe ( out patients 25% and in 
patients 35%). And moderate in (75% of out patients and 65% of in patients),. Hence the 
score will be gradually decreased during treatment. And finally after the study (30% of out 
patients and 25% of in patients) have no symptoms.  P<0.0001 was considered statistically 
significant difference. 
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Table 23 : GRADING OUTCOMES OF THE STUDY 
            
sl no Types of Grading 
Out patients In patients 
No. of 
Cases Percentage 
No. of 
Cases Percentage 
1 Good 12 60% 10 50% 
2 Moderate 8 40% 10 50% 
3 Poor 0 0% 0 0% 
 
Figure 23 : GRADING OUTCOMES OF THE STUDY 
 
 
Inference: 
               From the above table that  majority of (out patients 60% and in patients 50%)  have 
good response. Moderate response were observed in (40% of out patients and 50% of in 
patients). Thus the trial drug is very effective in curing kalladaippu noi. 
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CASE SHEET OF 20 OUT PATIENTS TREATED FOR KALLADAIPPU NOI 
S.NO OP.NO NAME AGE SEX STARTING OF TREATMENT 
END 
OFTREATMENT. 
NO OF 
DAYS 
TREATED 
RESULT 
1. 65904 Muthu Kumar 25 M 02/08/2017 03/09/2017 30 DAYS FAIR 
2. 68450 Ajanthan 37 M 10/08/2017 10/09/2017 30 DAYS     GOOD   
3. 78294 Sadhish Kumar 34 M 11/09/2017 11/10/2017 30 DAYS GOOD 
4. 79107 Ganapathy 35 M 13/10/2017 13/10/2017 30 DAYS GOOD 
5. 79499 Pushpam 43 F 13/10/2017 13/10/2017 30 DAYS GOOD 
6. 83818 Velvizhi 42 F 27/09/2017 27/10/2017 30 DAYS GOOD 
7. 89095 Anbalagan 37 M 12/10/2017 12/11/2017 30 DAYS GOOD 
8. 98352 Muthu Kumar 29 M 08/11/2017 09/12/2017 30 DAYS FAIR 
9. 99207 Pushpalatha 40 F 10/11/2017 10/12/2017 30 DAYS FAIR 
10. 7286 Venkatachalam 45 M 28/01/2018 28/02/2018 30 DAYS FAIR 
11. 16863 Manikandan 23 M 02/03/2018 02/04/2018 30 DAYS FAIR 
12. 21195 Malar Vizhi 22 F 05/03/2018 05/04/2018 30 DAYS GOOD 
13. 33767 Shunmuga Sundarraj 23 M 10/04/2018 10/05/2018 30 DAYS GOOD 
14. 33771 Karthicka 26 F 12/04/2018 12/05/2018 30 DAYS GOOD 
15. 34676 Sherma Pandian 34 M 23/04/2018 23/05/2018 30 DAYS GOOD 
16. 37388 Padma 48 F 23/04/2018 23/05/2018 30 DAYS GOOD 
17. 37393 Manimegalai 27 F 25/04/2018 25/05/2018 30 DAYS GOOD 
18. 38700 Vimala 46 F 28/04/2018 28/05/2018 30 DAYS FAIR 
19. 38615 Annamalai 33 F 30/04/2018 30/05/2018 30 DAYS FAIR 
20. 38691 Saraswathy 38 F 30/04/2018 30/05/2018 30 DAYS FAIR 
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BLOOD INVESTIGATION 
S. 
No. 
OP 
No 
Before Treatment After Treatment 
WBC 
Total cells / 
cub.mm 
WBC-DC% ESR HB 
WBC 
Total cells 
/ cub.mm 
WBC-DC% ESR HB 
P L E ½ hr 1 hr P L E ½ hr 1 hr 
1. 65904 7300 66 30 4 - 21 12 6400 62 34 4 - 18    13 
2. 68450 7000 60 36 4 - 12 13 6800 59 40 1 - 18    13 
3. 78294 6500 62 35 3 - 15 13.7 7000 64 33 3 - 18  13.8 
4. 79107 7200 54 45 1 - 15 12.4 8000 55 43 2 - 12  12.6 
5. 79499 7600 64 32 4 - 20 9.8 7400 62 34 4 - 18    10 
6. 83818 7500 64 27 4 - 16 10.5 7300 58 30 7 - 20    10 
7. 89095 6800 64 32 4 - 24 12.6 7200 63 30 7 - 20  11.8 
8. 98352 8000 60 36 4 - 15 14.3 7600 60 38 2 -   20    14 
9. 99207 9800 64 33 1 - 15 11.5 8800 68 30 2 - 18    12 
10. 7286 8000 58 41 1 - 25 13.5 7500 62 35 3 - 18  12.8 
  11. 16863 8800 63 34 3 - 18 11.5 8200 58 40 2 - 18    14 
12. 21195 9300 60 35 5 - 12 10.5 8600 68 32 - - 16    11 
13. 33767 6900 76 20 4 - 15 14 8200 66 28 6 - 22  13.6 
14. 33771 9800 64 33 3 -    15 11.5 8600 70 30 - - 22    11 
15. 34676 7000 58 38 4 - 15 12.5 7100 64 30 6 - 30    13 
16. 37388 7500 68 29 3 - 17 13 7900 64 32 4 - 21  13.4 
17. 37393 7500 67 29 4 - 10 10.5 8000 62 38 - - 12  11.2 
18. 38700 7300 60 37 3 - 10 11.6 7000 64 32 4 - 15    11 
19. 38615 8000 60 36 4 - 12 14.4 7800 62 33 5 - 18    14 
20. 38691 7800 58 31 1 - 16 11.6 7400 62 36 2 - 24    12 
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BIOCHEMICAL ANALYSIS 
 
 
S.NO 
 
OP.NO 
Blood Sugar Blood Urea Total Cholesterol Serum creatinine Bilirubin 
BFT AFT BFT AFT BFT AFT BFT AFT BFT AFT 
1. 65904 93 89 22 20 139 175 0.6 0.4 0.5 0.2 
2. 68450 114     102 20 26 136 180 0.4 1.0 0.2 0.4 
3. 78294 88 120 31 30 125 143 0.7 0.5 0.5 0.3 
4. 79107 96 94 22 18 150 123 0.4 0.2 0.2 0.3 
5. 79499 80 96 25 22 216 200 0.6 0.6 0.5 0.2 
6 83818 84 102 23 22 146 160 0.6 0.4 0.5 0.2 
7. 89095 114 101 16 15 126 138 0.4 0.2 0.2 0.3 
8. 98352 67 95 22 18 142 165 0.6 0.5 0.4 0.2 
9. 99207 95 102 20 18 148 132 0.4 0.6 0.2 0.4 
10. 7286 116 95 22 20 160 129 0.4 0.5 0.2 0.3 
11. 16863 102 96 21 18 130 131 0.5 0.4 0.4 0.2 
12. 21195 89 104 16 15 128 136 0.5 0.2 0.4 0.3 
13. 33767      113 95 16 24 110 142 0.7 0.3 0.5 0.2 
14. 33771 116 120 20 18 128 140       1.0 0.9 0.2 0.3 
15. 34676 122 102 18 20 139 180 0.7 0.4 0.4 0.5 
16. 37388 130 142 16 20 206 178 0.7 0.6 0.2 0.2 
17. 37393 97 80 25 23 137 104 0.8 0.5 0.4 0.3 
18. 38700 117 128 21 18 166 126 0.8 0.4 0.5 0.3 
19. 38615 65 96 26 20 144 126 0.9 0.8 0.5 0.3 
20. 38691 96 104 18 22 162 146 0.4 0.2 0.2 0.1 
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URINE ANALYSIS 
S.NO OP.NO Before Treatment After Treatment 
Alb Sugar Pus 
cells 
Epi. 
cells 
RBC’S casts/crystals Alb Sugar Pus Epi. 
cells 
RBC’S casts/crystals 
1. 65904 Nil Nil 1-2 NAD 0-3 NAD Nil Nil 0-1 NAD NAD NAD 
2. 68450 Nil Nil 2-5 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
3. 78294 Nil Nil 5-7 1-2 NAD NAD Nil Nil 1-2 0-1 NAD NAD 
4. 79107 Nil Nil 1-2 2-3 NAD NAD Nil Nil NAD NAD NAD NAD 
5. 79499 Nil Nil 2-5 1-2 NAD NAD Nil Nil 0-1 NAD NAD NAD 
6. 83818 Nil Nil 5-7 Plenty NAD NAD Nil Nil 0-2 1-2 NAD NAD 
7. 89095 Nil Nil 0-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
8. 98352 Nil Nil 1-2 3-4 NAD NAD Nil Nil NAD 0-1 NAD NAD 
9. 99207 Nil Nil 1-2 2-3 NAD NAD Nil Nil NAD 0-1 NAD NAD 
10. 7286 Nil Nil 2-3 3-5 NAD NAD Nil Nil NAD 0-2 NAD NAD 
11. 16863 Nil Nil NAD few few calcium 
oxalate 
crystals 
Nil Nil NAD 0-2 0-1 NAD 
12. 21195 Nil Nil few NAD NAD NAD Nil Nil 0-1 NAD NAD NAD 
13. 33767 Nil Nil NAD 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
14. 33771 Nil Nil 1-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
15. 34676 Nil Nil 5-8 3-5 NAD NAD Nil Nil 0-1 NAD NAD NAD 
16. 37388 Nil Nil few 1-2 NAD NAD Nil Nil 0-1 NAD NAD NAD 
17. 37393 Nil Nil 3-5 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
18. 38700 Nil Nil 1-2 2-3 NAD NAD Nil Nil NAD NAD NAD NAD 
19. 38615 Nil Nil 1-2 NAD NAD Full of                    
calcium 
oxalate 
Nil Nil NAD NAD NAD NAD 
20. 38691 Nil Nil 1-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
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CASE SHEET OF 20 IN PATIENTS TREATED FOR KALLADAIPPU NOI 
S.NO IP.NO NAME AGE SEX Starting of 
treatment 
End of treatment No.of days 
treated 
Result 
1. 2513 Karuppasamy 29 M 09/09/2017 10/10/2017 30 Days Good 
2. 2819 Paramasivan 45 M 21/10/2017 20/11/2017 29 Days  Fair 
3. 3044 Murugan 40 M 14/11/2017 10/12/2017 26 Days Good 
4. 3047 Krishna 21 M 14/11/2017 14/12/2017 30 Days Good 
5. 3286 Navaneetha Krishnan 39 M 15/12/2017 10/01/2018 25 Days  Fair 
6.  588 Muruganantham 52 M 05/03/2018 31/04/2018 28 Days  Fair 
7.  689 Ganeshan 48 M 13/03/2018 13/04/2018 30 Days Good 
8.  723 Krishna Raj 60 M 16/03/2018 10/04/2018 24 Days  Fair 
9.  950 Soundararaj 30 M 09/04/2018 08/05/2018 29 Days  Fair 
10. 1098 Murugesan 23 M 19/04/2018 17/05/2018 28 Days Good 
11. 1116 Meiyappan 28 M 21/04/2018 20/05/2018 29 Days  Fair 
12. 1203 Subburaj 40 M 21/04/2018 21/05/2018 30 Days Good 
13. 1208 Padmanaban 48 M 23/04/2018 13/05/2018 21 Days  Fair 
14. 2680 Chellammal 58 F 04/10/2017 14/11/2017 40 Days Good 
15. 3099 Lalitha shenbagam 60 F 21/11/2017 24/12/2017 33 Days  Fair 
16. 3240 Mangaiesawari 45 F 11/12/2017 14/01/2018 33 Days Good 
17.  437 Shenbagam 60 F 18/02/2018 10/03/2018 20 Days  Fair 
18.  520 Michaelammal 55 F 26/02/2018 26/03/2018 30 Days Good 
19. 1061 Subbammal 33 F 03/04/2018 03/05/2018 30 Days Good 
20. 1068 Shanthi 54 F 03/04/2018 30/04/2018 28 Days  Fair 
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BIOCHEMICAL ANALYSIS 
 
S.NO 
 
 
IP.N
O 
Before Treatment After Treatment 
WBC Total 
cells/ 
cub.mm 
WBC-DC% ESR  
Hb% 
WBC Total 
cells/ 
cub.mm 
WBC-DC% ESR  
Hb% P L E ½ 
hr 
1 hr P L E ½ hr 1 hr 
1. 2513 6800 58 38 4 - 20 10.9 7200 62 32 6 - 18 11.2 
2. 2819 6800 63 33 4 - 20 12.7 6600 68 30 2 - 22 12 
3. 3044 5900 51 40 5 - 12 15 6600 61 38 1 - 24 14.6 
4. 3047 7100 64 35 1 - 12 13 6900 58 40 2 - 18 13.4 
5. 3286 7600 70 27 3 - 20 10.5 7200 68 30 2 - 24 10.8 
6. 588 5400 52 47 1 - 30 10.8 5800 60 33 7 - 22 11.2 
7. 689 6900 54 38 8 - 30 11 6400 68 26 6 - 18 12.4 
8. 723 8000 72 25 3 - 26 12.4 7600 58 38 4 - 16 14 
9. 950 7500 58 40 2 - 28 13 7000 68 29 3 - 16 12.7 
10. 1098 7000 61 37 3 - 18 14 6600 62 35 3 - 32 13.2 
11. 1116 8100 62 31 7 - 30 10.2 6800 65 30 5 - 26 11 
12. 1203 7200 60 40 - - 18 9.8 7000 68 31 1 - 18 10.4 
13. 1208 5900 61 38 1 -s 24 15 6200 59 34 7 - 20 14.2 
14. 2680 6200 64 34 2 - 18 11.2 7400 62 37 1 - 22 12 
15. 3099 6500 64 30 6 - 30 11 6800 58 34 8 - 22 12.5 
16. 3240 6400 60 35 5 - 20 11.2 6800 62 34 4 - 18 11 
17. 437 6500 64 32 4 - 30 10.4 6700 66 32 2 - 24 11 
18. 520 5200 72 25 3 - 34 11 5000 58 40 2 - 28 11.5 
19. 1061 5800 58 40 2 - 30 12.4 5400 67 31 2 - 18 12 
20. 1068 6000 64 32 4 - 12 10 5800 65 33 2 - 17 10.8 
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BIOCHEMICAL ANALYSIS 
 
 
 
S.NO IP.NO Blood sugar 
Blood urea 
(mgs %) 
Total cholestrol 
(mgs %) Serum creatinine Bilirubin 
BFT AFT BFT AFT BFT AFT BFT AFT BFT AFT 
1. 2513 109 96 18 17 180 162 0.7 0.5 0.5 0.2 
2. 2819 88 96 15 22 162 158 0.6 0.7 0.5 0.2 
3. 3044 90 104 17 22 122 114 0.7 0.4 0.4 0.2 
4. 3047 100 94 20 21 186 165 0.3 0.2 0.5 0.2 
5. 3286 72 74 14 16 110 120 0.8 0.7 0.1 0.2 
6. 588 116 118 16 15 174 164 0.7 0.5 0.2 0.1 
7. 689 124 104 18 17 146 160 0.4 0.2 0.5 0.4 
8. 723 132 128 13 20 126 162 0.5 0.3 0.3 0.5 
9. 950 84 96 21 19 168 128 0.2 0.1 0.5 0.6 
10 1098 130 116 12 16 203 103 0.9 0.5 0.1 0.2 
11. 1116 100 96 11 12 182 128 1.0 0.8 0.6 0.4 
12. 1203 104 108 16 16 149 194 0.8 0.4 0.5 0.3 
13. 1208 90 100 17 18 122 116 0.7 0.5 0.4 0.2 
14. 2680 86 104 22 25 185 172 1.0 0.8 0.2 0.1 
15. 3099 86 104 16 20 164 156 0.6 0.2 0.4 0.1 
16. 3240 84 96 28 20 190 186 0.4 0.2 0.5 0.4 
17. 437 84 90 16 20 171 117 0.5 0.3 0.6 0.2 
18. 520 125 104 14 18 164 144 0.6 0.4 0.4 0.1 
19. 1061 111 120 18 20 182 128 0.3 0.4 0.3 0.1 
20. 1068 98 82 12 11 200 161 0.8 0.6 0.1 0.3 
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URINE ANALYSIS 
 
S.N
O 
 
IP.N
O 
Before Treatment After Treatment 
Al
b 
Sug
ar 
Pus cells Epi. 
cells 
RBC’
S 
Casts/ 
crystals 
Al
b 
Suga
r 
Pus 
cells 
Epi. 
cells 
RBC’
S 
Casts/ 
crystals 
1. 2513 Nil Nil few pus 1-2 NAD NAD Nil Nil 1-2 Pus NAD NAD NAD 
2. 2819 Nil Nil 1-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
3. 3044 Nil Nil 1-4 NAD NAD NAD Nil Nil 0-1 NAD NAD NAD 
4. 3047 Nil Nil 1-2 0-1 NAD NAD Nil Nil NAD NAD NAD NAD 
5. 3286 Nil Nil NAD 0-2 NAD NAD Nil Nil NAD NAD NAD NAD 
6. 588 Nil Nil 2-5 NAD NAD NAD Nil Nil 0-1 NAD NAD NAD 
7. 689 Nil Nil 2-4 NAD NAD NAD Nil Nil 0-2 NAD NAD NAD 
8. 723 Nil Nil NAD 0-4 NAD NAD Nil Nil NAD NAD NAD NAD 
9. 950 Nil Nil NAD 1-2 0-2 NAD Nil Nil NAD NAD NAD NAD 
10. 1098 Nil Nil 0-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
11. 1116 Nil Nil NAD 0-1 NAD NAD Nil Nil NAD NAD NAD NAD 
12. 1203 Nil Nil 0-4 NAD NAD NAD Nil Nil 0-1 NAD NAD NAD 
13. 1208 Nil Nil 1-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
14. 2680 Nil Nil NAD 0-2 NAD NAD Nil Nil NAD NAD NAD NAD 
15. 3099 Nil Nil 1-4 NAD 0-1 NAD Nil Nil NAD 0-1 NAD NAD 
16. 3240 Nil Nil NAD 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
17. 437 Nil Nil 1-2 1-2 NAD NAD Nil Nil 0-1 NAD NAD NAD 
18. 520 Nil Nil NAD NAD NAD NAD Nil Nil NAD NAD NAD NAD 
19. 1061 Nil Nil 2-5 NAD NAD few crystals Nil Nil NAD 0-1 NAD NAD 
20. 1068 Nil Nil NAD 0-2 1-2 NAD Nil Nil NAD NAD NAD NAD 
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CHAPTER V 
 
                                                               DISCUSSION 
 
 
My clinical study is “To evaluate the therapeutic efficacy of Open Labelled 
Randamized  trial drug of “SIRU NERUNJIL KUDINEER” (Internal) in the 
treatment of KALLADAIPPU (Urolithiasis). Out of 20 out patients and 20 in patients 
were selected based on clinical features and modern investigations parameters and 
siddha diagnostic methods (Envagai Thervugal) were carried out after the disease.It is 
confirmed by ultrasonagram. The trial drug “SIRU NERUNJIL KUDINEER” was 
prepared and given to the patients. The blood, urine samples and other general details 
were collected from the patients before and after treatment. The urolithiasis 
symptoms score of each patient before and after treatment were compared to assess 
the therapeutic value of the trail drug “SIRU NERUNJIL KUDINEER”. 
 
 
AGE 
 
In this study, among the 20 out-patients, Kalladaippu noi was  most common 
in Pitha Kaalam 34-66 years (60%). and among the 20  in-patients, it was 
predominant (70%) in Pitha Kaalam 34-66 years. 
 
 
SEX 
 
 From the study, among the 20 outpatients (50%) were Male and (50%) were 
Female. Whereas among inpatients majority of them were Males (65%) and (35%) 
were Female cases. 
 
 
 
OCCUPATION 
 
From the data collected during the enrollment of patients it was learnt that 
30% of the outpatients were House Wives, and 30% of the inpatients were Sedentary 
Workers. 
 
            DIETARY HABITS 
 
Out of the 40 cases who were recruited for the study majority of them (85% of 
outpatients and 80% of inpatients) were taking  Both Vegetarian and Non-Vegetarian 
items. 
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            MARITAL STATUS: 
 
 From the data collection, among the 40 patients majority of them (75% of        
out patients and 85% of in patients) were Married. 
 
PERSONAL HABITS 
 
From the history taken from the patients it was noted that 75% of outpatients 
and 60% inpatients does not have any Bad Habits. 25% of outpatients and 40% 
inpatients have Alcoholism, Smoking, Alcohol with Smoking. 
 
PARUVAKAALAM 
 
In General, Kalladaippu Noi occurs in all the seasons. But in the present 
study, it was found to be the commonest during Ilavenil Kalam (30% outpatients 30% 
of inpatients) were affected. 
 
 
 
THINAI 
 
Among the patients who were selected for the trial 65% of the outpatients and 
80% of the inpatients were from Marutha Nilam. 35% of outpatients were from 
Neithal Nilam, and 20% of inpatients were from Neithal Nilam. 
 
 
THEGI (CONSTITUTION OF BODY) 
 
In this study,Vatha Thegi patients were found to be the most affected by 
Kalladippu noi (60% of outpatients and 65% of inpatients), The second major were 
Pitha Thegi (30% of outpatients and 20% inpatients). Only a few of them (10% of 
outpatients and 15% of inpatients) were Kabam Thegi. 
 
 
 
              MANO THATHUVAM (GUNAM) 
 
In this study, Rajo Gunam patients was affected by Kalladaippu noi (80% of 
out patients and 70% of in patients). The second major were Sathuva Gunam (15% of 
out patients and 15% of in patients). Only few of them (5% of out patients and 15% 
of in patients) were Thamo Gunam. 
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UYIR THATHUKAL 
 
 
A. DERANGEMENT OF VATHAM 
 
In the contemporary study, it was noted that all the patients under treatment 
had disturbances in Abaanan and Samanan (100%)  which was the primary cause for 
oliguria, dysuria and formation of calculi. Pranan was affected in 5% of outpatients 
and 10% of  inpatients has cold and cough experienced by the patients. Derangement 
in Dhevathathan (10% of outpatients and 15% of inpatients) causes tiredness in the 
patients, and disturbances in Nagan resulted in (10% of outpatients and 20% 
inpatients). Derangement in Koorman was affected in 25% of inpatients. 
 
B. DERANGEMENT OF PITHAM 
 
It was noted that Sadhaga Pitham was affected in 80% of outpatients and 60% 
of inpatients resulting in power to complete the task and difficulty in their regular 
work in day to day life. Ranjaga Pitham was found to be disturbed in 5% of 
outpatients and 15% of inpatients. 
 
C. DERANGEMENT OF KAPAM 
 
Santhigam was found to be affected in 5% of outpatients and 15% of 
inpatients, causing joint pain in elderly patients. 
 
 
UDAL THATHUKKAL 
 
Among the patients selected for the study Saaram (50% of out patients and 
30% of in patients) was affected  causing sluggishness. Moolai  thaathu was found to 
be affected in 40% of outpatients and 30% of inpatients and they suffered from 
Oliguria. Enbu Thathu was found to be affected in (10% of out patients and 30% of 
inpatients) due to joint pain. Senneer was found to be affected in 15% of outpatients 
and 30% of inpatients. 
          
  KOSANGAL 
               Among the 40 patients, Annamayakosam (100%) was affected in all patients 
due to Udal Thathukal. Pranamayakosam was affected in ( 5% of out patients and 
10% of in patients) due to Pranan i.e cold and cough. 
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          14 VEGANGAL 
               Among the 40 cases, controlling of  Siruneer (100%) was affected in all 
patients leads to Oliguria, Dysuria and Haematuria. Controlling of Thummal was 
affected in few cases (10% of out patients and 15% of in patients) leads to Oliguria 
 
 
ENVAGAI THAERVUGAL 
 
In this study, Moothiram (100%) was affected in all the patients. Naa was 
affected in ( 5% of outpatients and 15% of inpatients) have  fissures, pallour in their 
tongue. Vizhi was affected in ( 25% of in patients) due to visual disturbances. Vatha 
Pitha Naadi was felt in most of the patients (60% of outpatients and 50% of 
inpatients).The second major type of  Naadi was Pitha Vatha Naadi (35% of 
outpatients and 45% of inpatients).It was noticed that only 5% of the outpatients 5% 
of the inpatients had Vatha Kabha Naadi. and 5% of inpatients affected by Pitha 
Kabha Naadi. 
 
NEERKURI 
 
It was noted that the urine colour was Yellowish ( 65% of outpatients and 
75% inpatients) and Yellowish Red in (10% of  out patients and 5% of in patients), it 
was normal in 15% of outpatients and 10% of inpatients. Nurai  normal in all the 
patients. Edai was affected in all the 40 patients (100%) due to Haematuria, Dysuria, 
and mixed with Calculus. Maanam was affected in all the patients (100%) due to 
Fleshy, Charred ,Ketotic Odour. Enjal was affected in ( 40% of out patients and 30% 
of in patients) due to Oliguria, Haematuria. 
 
 
NEIKURI 
 
When Neikuri was tested in the urine samples of the patients it was observed 
that  majority of them (45% of outpatients and 40% of inpatients) revealed that Vatha 
Neer. (30% of outpatients and 45% of inpatients) were Pitha Neer. (25% of out 
patients and 15% of in patients) were Kapha Neer. 
 
 
DURATION OF ILLNESS 
 
Majority of the patients experienced symptoms of Kalladaippu noi only in the 
past 2-6 months period (35% of outpatients and 40% of inpatients) and 6 months – 1 
year (30% of outpatients and 20% of inpatients). (15% of outpatients and inpatients) 
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suffered from the disease from 1-11/2 years. Less than 2 months ( 20% of out patients 
and 25% of in patients) were affected 
 
           NUMBER OF STONES 
Before treatment majority of them have Single Stone (60% of out patients and 
70% of in patients), and Multiple Stones (40% of out patients and 30% of in patients). 
But after treatment (50% of out patients and 55% of in patients) have Single stone 
(Reducing in size of the stone) and Multiple Stones (20% of out patients and in 
patients) were affected. 
 
POSITION OF STONES 
 
The USG reports of the patients have stones which were mostly (40% of 
outpatients and 45% of inpatients) present in Left Kidney. In Right Kidney calculi 
were comparatively lesser (30% in outpatients and 35% in inpatients) and (20% of 
outpatients and 15% of inpatients) had stones in Both Kidneys. In Left Ureter (10% of 
out patients and 5% of inpatients). 
            
             SIZE OF STONES 
 
The USG reports of the cases before treatment showed that majority of the 
cases (55% of the outpatients and 65% of the inpatients) presented with stone of size 
5mm and above. And 4-5mm (30% of out patients and 20% of in patients). And 1-
3mm (15% of out patients and in patients) were affected. After treatment  (30% of out 
patients and 25% of in patients) have normal study report and have no symptoms. 
Thus the Statistics Analysis also considered as SIGNIFICANT P<0.0001. 
             
            UROLITHIASIS SYMPTOMS SCORE  
                From the above study, Before treatment the patients  (25% of out patients 
and 35% of in patients) were Severely affected. And (75% of out patients and 65% in 
patients) were Moderately affected. After treatment most of  the patients (30% of out 
patients and 25% of in patients) have No Symptoms that is Normal Study and also 
Relief in Symptoms. And (55% of out patients and 50% of in patients) have Mild 
scores. And also (15% of out patients and 25% of in patients) have Moderately 
affected ( reducing in stone size and relief in symptoms). Thus the Analysis also 
considered as SIGNIFICANT P<0.0001. 
 
88 
 
 
           STONE ANALYSIS 
 
Stones were received from  patient  at the end of the treatment. Stones were 
analysed in a well reputed laboratory to determine the composition of stones. The 
analysis of the stones indicated the presence of calcium oxalate types of whewellite 
and weddellite. The stone analysis reports of the patients are enclosed as Annexure V. 
           
 
 GRADING OUTCOME OF THE STUDY 
 
The trail medicine selected for the clinical study was SIRU NERUNJIL 
KUDINEER - 40ml BD Morning & Evening . The present study proved the 
therapeutic values of the trial medicine which is evident from the Absence of Calculi 
and Symptoms associated with Kalladaippu Noi in majority of the patients. Good 
response was noticed in (60% of outpatients and 50% of inpatients) and Moderate 
response in (40% of outpatients and 50% of inpatients). The good and moderate 
response of trial drug in treating Kalladaippu noi is attributed to the lithotriptic, 
diuretic and analgesic effects of the trial medicine. 
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CHAPTER-VI 
SUMMARY 
 
 The aim of the study is “ To Evaluate the Therapeutic Efficacy of the drug   “SIRU 
NERUNJIL KUDINEER” in KALLADAIPPU. 
 Before intiating the clinical trial, got approval from INSTITUTIONAL ETHICAL 
COMMITTEE (IEC) in Government Siddha Medical College. Palayamkottai. 
Tirunelveli. And got approval from INSTITUTIONAL ANIMAL ETHICAL 
COMMITTEE (IAEC) at SASTRA University, Thanjavur. 
 The trial were authenticated, and also done Biochemical Analysis in Govt. Siddha 
Medical College, Palayamkottai. Tirunalveli. 
 The trial drug undergo Physiochemical Analysis at Chennai Testing Laboratory, 
Chennai. And also Pharmacological Study done at SASTRA University, Thanjavur. 
Microbial study also done at Malar Diagnostic Centre at Tirunelveli. 
 For clinical study, among 40 cases were selected and recruited for the clinical trial, 
clinical diagnosis made by both Siddha and modern methodology. 
 Before initiating the trial informed consent was obtained from the patients. 
 The patients were treated for a period of 30 days. The trial medicine selected for 
internal treatment was SIRU NERUNJIL KUDINEER at the dose of 40ml twice a 
day referred under Siddha literature GUNAPAADAM MOOLIGAI Page.no.597. 
 Required laboratory investigations were carried out before and after treatment and the 
concerned data was recorded in the proforma. 
 Clinical assessment was done during each visit in OPD Patients (7days once) and the 
data was noted in the prescribed proforma. 
 During the study period there was no event of any adverse reactions owing to the drug 
and disease. 
 The patients were showed good prognosis within a short period, Oliguria and Burning 
Micturation reduced within 7 days of treatment.  
 It is observed that all other signs and symptoms relived at the end of course of 
treatment with the trial medicine and strict diet restriction.  
 From the clinical examination and enquiring the patients, it was noted that stones 
were broken into fragments and expelled out in the form of sand grains and gravels 
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with urine. It is evident from the ultrasonographic investigations that the trial 
medicine helped in disintegrate of the calculus in some patients. 
 Statistical Analysis of Urolithiasis Symptoms Score also shows significant P<0.0001. 
 Among 40 cases, Good response was noticed in 60% of OPD and 50% of IPD. And 
Moderate response in 40% of OPD and 50% of IPD.  
 In this study, it has been proved that the trial medicine, SIRU NERUNJIL 
KUDINEER (Internal) is highly effective and economically viable in curing 
KALLADAIPPU NOI. 
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CHAPTER VII 
 
CONCLUSION 
 
 
The following conclusions have been drawn from the A Prospective Open 
Labeled Randomized Clinical Trial on “The evaluation of efficacy of the trial drug, 
(internal) in SIRU NERUNJIL KUDINEER treating KALLADAIPPU NOI”, was 
carried out at the PG Department of Pothu Maruthuvam, Government Siddha Medical 
College and Hospital, Palayamkottai as my dissertation work. 
 
1. The Ingredients incorporated in the trial medicine helped to cure Kalladaippu 
Noi by compensating the increased Pitham which is attributed to the Diuretic, 
Lithotriptic action, Analgesic effect, as mentioned in the various Siddha 
Literatures - Annexure I.  
 
2. The Biochemical Analysis of trial medicine revealed that the presence of 
various minerals like Calcium, Sulphate, Chloride, Ferrous Iron and 
Unsaturated Compounds - Annexure II.  
 
3. The Physiochemical Analysis of  trial medicine shows determination of Total 
ash, Insoluble ash and Moisture Content it was within acceptable range. It 
indicates the longer shelf life period. The Microbial test shows Bacteria and 
Fungi are less condaminated, and  pathogens like Salmonella is absent. And 
other pathogens are lessly present.– Annexure III.  
 
4. The Pharmacological Study on trial medicine revealed the Lithotriptic Effect 
of the trial medicine – Annexure IV.  
 
5. The Microbial Analysis showed very sensitive to my trial drug of siru nerunjil 
kudineer of E.coli, Pseudomonas aeruginosas, Streptococcus Pneumonia, 
Klebsiella Pneumonia – Annexure V.  
 
6. The Ultra Sonogram Reports of some  patients Before treatment and After 
treatment were compared to evaluate the prognosis in patients – Annexure VI  
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7. The Analysis of Stone of the patient revealed that the presence of Calcium 
Oxalate type of  Whewellite and Weddellite - Annexure VI 
 
8. Clinically, the trial medicine is free from side effects as no patient experienced 
side effects during the course of treatment. 
 
9. The result showed Good Response in 60% of OPD and 50% of IPD  and 
Moderate Response in 40% of OPD  and 50% of IPD. 
 
The Trial Medicine was found to have Lithotriptic, Diuretic, Analgesic effect, 
and have properties to compensate the increased Pitham, which is one of the 
important causes for Kalladaippu Noi.  From this study, it has been proved that the 
trial medicine of SIRU NERUNJIL KUDINEER is highly effective in curing 
KALLADAIPPU NOI. 
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ANNEXURE I 
PREPARATION OF TRIAL MEDICINE 
! sqX!ofVR<sqz<!GcfQi< < Q< < Q< < Q < << < < << <!(SIRU NERUNJIL KUDINEER)  
 
OsVl<!svg<Ggt<;< < << < << < < !
! sqX!ofVR<sqz<!gib<! .! 79!gqvil<!
! ogik<klz<zquqjk! ! .! 9!gqvil<!
! k{<{Qi<! ! ! .! 791!gqvil<!
!
osb<Ljx;<<< !
! ofVR<sqz<! gib<! lx<Xl<! ogik<klz<zq! uqjk! -v{<jmBl<! gib! juk<K!
ye<xqv{<mig! -ck<K! Okjubie! ntU! fQi<! uqm<M! njk! Ofi<hikq<big!
S{<mjuk<K!ucgm<c!ogiMk<K!uvUl</!
! !
ntU!; 
 
 51!lq/zq!)-VOujt*!
!
kQVl<!Ofib<gt<;Q < < <Q < < <Q < < < !
!
! fQvjmh<H?!sjkbjmh<H?!gz<zjmh<H?!fQv<wiqs<sz<!
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sqX!ofVR<sqz<< << << <!gib<<<<! ! ! !!!!ogik<Klz<zq!uqjk< << << < !
!
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PROPERTIES OF THE TRIAL MEDICINE DRUGS 
 
TRAIL MEDICINE : SIRU NERUNJIL KUDINEER. 
 
Ingredients 
1. sqX!ofVR<sqz<!gib< 
2. ogik<klz<zq!uqjk 
!
2/!sqX!ofVR<sqz<!gib<;!)< < << < << < < Tribulus terrestris) 
 !
! OuXohbi<!! ;! kqiqg{<ml<?!kqiqg{<mgl<?!kqiqk{<ml<?!Ogi{<ml<?!
Sukm<ml<!nSusm<cvl<?!SuiKg{<ml<?!ofVR<sqHKl<?!
gigvsq?!gkzq!
!
! English Name: Small Caltrops, Land Caltrops, Punol – ure – vine 
 
 Family  : Zygophyllaceae 
 
 Sju!! ;! Kui<h<H?!-eqh<H!
!
! osb<jg! ;! Gtqi<s<sqB{<mig<gq?!sqXfQi<ohVg<gq?!dt<tpzix<xq?!
dvlig<gq?!N{<jlh<ohVg<gq?!Kui<h<hq/!
!
ohiKG{l<!;<<< !
! !
! ! “fz<zofVR<sqzKfiTr<gqiqs<sivk<jk!
! ! uz<zSvlejzlix<Xr<gi{<!.!!olz<zqbOu"!
! ! lifqzk<kqz<!gz<zjmh<Hl<!uir<gikfQi<g<gm<Ml< < < < Q < < << < < < Q < < << < < < Q < < < <!
! ! %EXolb<!uikLl<!Ohig<Gl<”!
!
!
kQVl<!Ofib<gt<;Q < < <Q < < <Q < < < !
!
! osim<MfQi<?!gz<zjmh<H?!fQvjmh<H!?fQi<wiqs<sz<?!SvouKl<hz<?!Lg<Gx<xl<?!
fQi<Oum<jg?!ouh<hl<!
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2/!ogik<Klz<zq<!uqjk;!)< < << < << < < Coriandrum sativum ) 
 !
! OuXohbi<!! ;! dVt<!niqsq?keqbi!
!
! English Name: Coriander seeds  
 
 Family : Umbiliferaceae 
 
 Sju!! ;! gii<h<H!
!
osb<jg! ;! hsqk<kQk<K~{<c?!ngm<Muib<ugx<xq?!ouh<hL{<mig<gq?!
sqXfQi<ohVg<gq!
!
ohiKG{l<!;<<< !
! !
! ! “ogik<Klz<zqouh<hl<!Gtqi<gib<s<sz<!hqk<klf<kR<!
si<k<kquqg<gz<!kigoliMkiKfm<ml<< << << <!.!Sk<kqobPl<!
uikuqgii<lmi<!ue<gi<k<khquqv{l<!< < < < < << < < < < << < < < < < !
H,kzk<kqz<!zikgx<Xl<!Ohix<X”!
!
!
kQVl<!Ofib<gt<;Q < < <Q < < <Q < < < !
!
! dm<S,M?!ftqi<s<Svl<?!jhk<kqbOfib<?!osiqbijl?!uif<kquqg<gz<?!fiuxm<sq?!
ohVWh<hl<?!H{<!-juOhiGl</!
!
!
!
!
!
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ANNEXURE II 
BIO-CHEMICAL ANALYSIS OF SIRU NERUNJIL KUDINEER 
 
PREPARATION OF THE EXTRACT 
5 gm of drug was weighted accurately and placed in a 250ml clean beaker then 50ml 
of distilled water is added and dissolved well. Then it is boiled well for about 10 minutes.  It 
is cooled and filtered in a 100ml volumetric flask and then it is made up to 100ml with 
distilled water.  This fluid was taken for analysis. 
 
QUALITATIVE ANALYSIS 
 
S. NO EXPERIMENT OBSERVATION INFERENCE 
1 
TEST FOR CALCIUM 
A White 
precipitate is 
formed 
Indicates the 
presence of 
calcium 
2 ml of the above prepared extract is taken in a 
clean test tube. To this add 2 ml of 4% 
ammonium oxalate solution 
2 
TEST FOR SULPHATE 
A white 
precipitate is 
formed 
Indicates the 
presence of 
sulphate 
2 ml of the extract is added to 5% barium 
chloride solution 
3 
TEST FOR CHLORIDE 
A white 
precipitate is 
formed 
Indicates the 
Presence of 
chloride The extract is added with silver nitrate solution 
4 
TEST FOR CARBONATE 
No brisk 
effervescence is 
formed 
Absence of 
carbonate The extract is treated with concentrated HCL 
5 
TEST FOR STARCH 
No blue color is 
formed Absence of starch The extract is added with weak iodine solution 
6 
TEST FOR FERRIC IRON 
No blue colour is 
formed 
Absence of ferric 
iron The extract is acidified with glacial acetic acid 
and add potassium ferrocyanide 
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7 
TEST FOR FERROUS IRON 
Blood red colour 
is formed 
Indicates the 
presence of 
ferrous iron 
The extract is treated with concentrated nitric 
acid and ammonium thiocyanate solution 
8 
TEST FOR PHOSPHATE 
No yellow 
precipitate is 
formed 
Absence of 
phosphate The extract is treated with ammonium 
molybdate and concentrated nitric acid 
9 
TEST FOR ALBUMIN 
No yellow 
precipitate is 
formed 
Absence of 
albumin The extract is treated with Esbatch’s reagent 
10 
TEST FOR TANNIC ACID 
No blue black 
precipitate is 
formed 
Absence of tannic 
acid The extract is treated with ferric chloride 
11 
TEST FOR UNSATURATION 
It gets 
decolourised 
Indicates the 
presence of 
unsaturated 
compounds 
Potassium permanganate solution is added to 
the extract 
12 
TEST FOR REDUCING SUGAR 
No colour 
change occurs 
Absence of 
reducing sugar 
5 ml of benedict’s qualitative solution is taken 
in a test tube and allowed to boil for 2 minutes 
and add 8- 10 drops of the extract and again 
boil it for 2 minutes 
13 
TEST FOR AMINO ACID 
No violet colour 
is formed 
Absence of 
Amino acid 
One or two drops of the extract is placed on a 
filter paper and dried well. After drying 1% 
Ninhydrin is sprayed over the same and dried 
well 
14 
TEST FOR ZINC 
No white 
precipitate is 
formed 
Absence of zinc The extract is treated with potassium 
ferrocyanide 
 
INFERENCE 
 The given sample of the trail drug SIRU NERUNJIL KUDINEER contains 
Calcium, Sulphate, Chloride, Ferrous Iron and Unsaturated Compounds. 
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ANNEXURE III 
PHYSIO CHEMICAL ANALYSIS 
 
Interpretation: 
 The Total ash value, Iinsoluble ash, and Water soluble extract, Moisture 
content it was within acceptable range. It indicates the longer shelf life period. The amount of 
minerals and earthy materials present in the drug material. 
                          The total bacterial count, and the total fungal count of the drug were found 
that the drug is less from microbial condamination. The other pathogens like Salmonella is 
absent, Escherichia coli, Staphylococcus aureus, Pseudomonas are lessely present. 
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TOXICOLOGY REPORT 
 
 
Report Date      : 05.07.2018 
 
SR No.     : CAF/S/168 
 
Sample ID No.    : 246 
 
Sample Name     : SIRO Nerungil Kudineer 
 
Identification and condition of the test item  : Samples received in good condition 
      
Test item received on     : 09.03.2018 
 
Sample description     : Powder  
 
Report prepared on     : 03.07.2018 
 
Name & address of the customer  : Ms.Seethalakshmi 
        Govt. Siddha College 
        Palayamkottai. 
 
 
 
 
Name & Address of the Testing Laboratory 
Central Animal Facility, SASTRA Deemed University, Thanjavur - 613 401. 
Email : panchapakesan@sastra.edu 
Phone : +914362-264101-108  Extn. 3680 
Fax : +914362-264120 
 
 
 
 
This report contains nine pages and this report shall not be reproduced  
except in full without the written approval of the laboratory. 
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Methods 
 
1. Standard procedure for Euthanasia & Necropsy  as per CARISM/SOP/CAF/01 
2. Standard procedure for Receipt, Handling and Preparation of test Substance as per 
CARISM/SOP/CAF/05 
3. Standard procedure for Route of Administration in animals as per CARISM/SOP/CAF/06 
4. Standard procedure for Animal Handling as per CARISM/SOP/CAF/07 
5. Standard procedure for Animal Identification as per CARISM/SOP/CAF/08 
6. OECD Guidelines for the Testing of Chemicals "Acute Dermal Toxicity-402" OECD 
Publishing, Paris. Adopted: 24 Feb 1987 
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TEST SYSTEM 
 
 
Test Species : Rattus norvegicus 
Strain : Wistar rats 
Age : Healthy young  adult animals between 8 and 12 weeks 
Source : Central Animal Facility, SASTRA Deemed University 
Number of Animals : 30 
Dose : 37.5, 75 and 150 mg/kg body weight 
Route of administration : Oral 
 
 
Acclimatization 
 
 Seven days prior to the experiment. 
 
Identification and treatment details of Animals  
 
 Tags  marked  with  animal  number,  group  number  and  dose  level  were  attached  to  
the respective cages. Each animal was identified by unique identification number by ear tagging. 
 
Group  
Group  
Description 
Number of 
animals 
Animal ID Treatment details 
I Normal control 6 10353-10358 Distilled water only 
II Diseased control 6 10359-10364 
Distilled water + Ethylene 
glycol (0.75%) in 
drinking water 
III Lower dose 6 10365-10370 
Ethylene glycol (0.8%) + 
Nerungil kudineer 
(37.5 mg/kg.  B wt. po) 
IV Medium dose 6 10371-10376 
Ethylene glycol (0.8%) + 
Nerungil kudineer 
(75 mg/kg.  B wt. po) 
V Higher dose 6 10377-10382 
Ethylene glycol (0.8%) + 
Nerungil kudineer 
(150 mg/kg.  B wt. po) 
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ANIMAL HUSBANDRY 
 
Animal House Condition 
 
Temperature of the test room was maintained between 22±3°C and relative humidity 
between 50 to 70 % during the experimental period.  The experimental room was provided 
with a 12h light and 12h dark lighting condition using an automatic timer. 
 
Housing 
 
 Standard polypropylene rat cages with stainless steel top grill was used to house the 
animals. The cages were autoclaved.  Sieved and sterilized paddy husk was used as the bedding 
material. Animals were housed individually. 
 
Sanitation 
 
 Bedding material, cages, grills and water bottles were changed weekly twice. 
 
Animal Welfare and Regulatory Compliance 
 
The  experiment  was  conducted  at  the  Central  Animal  Facility  registered (No. 
817/PO/ReRc/S/04/CPCSEA  dated 20.11.2015) for Breeding and Experiments  of Animals 
by the Committee for the Purpose of Control and Supervision of Experiments on Animals, 
Ministry of Forest and Environment, Govt. of India. 
 
The study was conducted after the approval by the Institutional Animal Ethical 
Committee, SASTRA University (IAEC Approval Number: 483/SASTRA/IAEC/RPP). 
 
Diet and Water 
 
 Standard rodent pellet feed supplied by M/s. ATNT Laboratories, Mumbai, India and 
Reverse Osmosis (RO) water were provided to the animals ad libitum. 
 
Preparation of Test Substance 
 
 The freshly prepared decoctions were orally administered to the experimental rats as 
mentioned above. 
 
 
 
 
 CARISM - SASTRA 
 TOXICOLOGY REPORT   
Report No Issue Date 
Page 5 of 9 
CARISM/CAF/TOX/CAF/S/168/2018-05 05.07.2018 
 
Analysed by         Authorised by  
  
Deputy Technical Manager-Toxicology                                         Technical Manager 
 
Experimental procedure 
 Male Wistar rats were divided into five groups of six each. 
 
 Urolithiasis in rats was be induced by treating  with 1% ammonium chloride plus 0.4% 
ethylene glycol for first week followed by 0.8% ethylene glycol alone up to 21 days in 
normal drinking water except Group 1  
 
 Groups III to V served as curative regimen and test drug was administered orally from 
15
th
 day till 28
th
 day.  
 
 On 28th day, urine samples were collected using metabolic cages for 24 hours and the 
volume of urine was measured. 
 
 The urine samples were analysed for calcium and phosphorus. 
 
 On 28th day, blood was collected from the retro-orbital under anesthetic conditions and 
the serum was separated by centrifugation at 10,000 × g for 10 min and was analyzed for 
urea, calcium, uric acid and Phosphorus. 
 
 On 28th day, after blood collection, animals were sacrificed and the kidneys were isolated 
from each animal.  
 
 Isolated kidneys were cleaned off extraneous tissue and preserved in 10% neutral 
formalin and processed for histopathological studies. 
 
 
Statistical Analysis  
 
The values are represented as mean±SD. Statistical differences between the treatments 
and the controls were tested by one-way analysis of variance (ANOVA) followed by the Tukey's 
multiple comparisons test using the “GraphPad prism 5”. A difference in the mean values of 
p<0.05 was considered to be statistically significant. 
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OBSERVATIONS 
 
Effect of test substance (246) on urine calcium level 
 
Values expressed as Mean ± SD, Statistical analysis was performed using ANOVA followed by the 
Tukey's test **p<0.01Vs Normal control, #p<0.05Vs Disease control. 
 
Effect of test substance (246) on urine phosphorus level 
 
Values expressed as Mean ± SD, Statistical analysis was performed using ANOVA followed by the 
Tukey's test **p<0.01Vs Normal control. 
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Effect of test substance (246) on urine volume 
 
Values expressed as Mean ± SD, Statistical analysis was performed using ANOVA followed by the 
Tukey's test ##p<0.01,#p<0.01Vs Disease control. 
 
Effect of test substance (246) on serum urea level 
 
 
Values expressed as Mean ± SD. 
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Effect of test substance (246) on serum uric acid level 
 
 
Values expressed as Mean ± SD. 
 
Effect of test substance (246) on serum calcium level 
 
Values expressed as Mean ± SD. 
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Effect of test substance (246) on serum phosphorus level  
 
 
 
Values expressed as Mean ± SD, Statistical analysis was performed using ANOVA followed by the 
Tukey's test ,*p<0.05Vs Normal control, #p<0.01Vs Disease control. 
 
RESULTS 
 
 Disease control group shows significant (p<0.01) increase in urine calcium level 
compared with normal control animals, whereas after treatment with test substance (246) 
showed significant (p<0.05) decrease in urine calcium level compared with disease control 
animals. 
 The experimental rats treated with ethylene glycol alone (Group 2) showed significant 
(p<0.05) increase in urine phosphorus level, whereas rats treated with test substance 
(246) showed decrease in phosphorus level but not significant. 
 Urine volume: Urolithiasis rats treated with test substance (246) showed dose dependent 
increase in urine volume compared with normal and disease control. This indicates that 
the test substance is possessing diuretic effect. 
 No significant changes were observed in serum calcium, urea and uric acid levels in rats 
treated with test substance (246). 
 Significant (p<0.05) increase in serum phosphorus level was observed in disease control 
group, whereas rats treated with test substance (246) at the dose level 150 mg/kg b wt. 
showed significant (p<0.05) decrease in serum phosphorus level compared with disease 
control group. 
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Annexure -V 
MICROBIOLOGICAL ANALYSIS OF SIRU NERUNJIL KUDINEER 
  By Kirby – Bauer method 
Aim  
To determine the anti-microbial activity of “ Siru Nerunjil Kudineer ”. 
Components of Muller Hinton Agar Medium 
Beef extract  - 300 grams/liter. 
Agar   - 17 grams/liter. 
Starch   - 1.5 grams/liter. 
Casein hydroxylate - 17.5 grams/liter 
Distilled Water - 1000ml. 
Ph   - 7.6. 
Procedure 
  The method of antimicrobial activity study is UPs Diffusion method. 
  Antibiotic discs are prepared with known concentration of antibiotic are placed on 
Agar plates that has been inoculated with the known pathogenic microorganism. 
  The antibiotic diffuses through the agar producing an anti-biotic concentration; 
gradient anti-microbial susceptibility is proportional to the diameter of the inhibitory zone 
around the disc. If the micro organism which grows up to the edge of the disc are resistant to 
the antimicrobial agent. 
  The recommended medium in this method is Muller Hinton Agar, its PH should be 
between 7.2 – 7.6 and should be poured to uniform thickness of 4mm in the petri plate 
(25ml). 
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Methodology 
  Muller Hinton Agar plates are prepared and (Escherichia coli, Klebsiella pneumoniae, 
pseudomonas aeruginosae, streptococcus pneumoniae are inoculated separately. 
The prepared discs of Nerunjil Kudineer  are placed over the incubated plate. 
  Using sterile forceps and incubated for 24 hours at 37ºcelcius. The plates after 24 
hours incubation are observed for the zone of inhibition. 
Result 
    Sl.No Test Drug Organism 
(Culture) 
Control 
Zone size 
    Test 
    Zone 
    Size 
Susceptibility 
 
1 
 
 
 
 
 
 
SIRU 
NERUNJIL 
KUDINEER 
 
 
 
 
 
 
Escherichia 
coli 
 
 
 
20mm 
 
17 mm 
 
 
Sensitive 
2 
 
 
Klebsiella 
pneumoniae 
 
15mm 13 mm 
 
 
 
Moderate 
Sensitive 
 
 
3 
 
 
 
 Pseudomonas 
 aeruginosae 
 
 
19mm 
 
18 mm 
 
 
 
Sensitive 
 
 
4 Streptococcus pneumoniae 
 
15mm 14 mm Sensitive 
 
Report 
Siru Nerunjil Kudineer  is sensitive to Escherichia Coli, Pseudomonas aeruginosae, 
Streptococcus pneumoniae. Moderately sensitive to Klebsiella pneumoniae. 
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ANNEXURE VII 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI – 2 
Department of Pothu Maruthuvam 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
Form I  
Screening and Selection proforma 
1. OP No. : ________   Date : __________ 
2. Name  : __________________ 
3. Age : _____   1.Vatha Kaalam (0-33 years) 
2.Pitha Kaalam (34 - 66 years) 
4. Gender :  1.Male   2.Female 
5. Blood group:  ________ 
6. Address : 
___________________________________________ 
___________________________________________ 
___________________________________________ 
___________________________________________ 
7. Contact No. : _____________________ 
 
Criteria for Selection:       Yes                 No  
 
1. Age 20-60 years       
2. Both Sex : Male     Female   
    
3. Patient with appropriate symptoms of  
Renal Colicky Pain 
(fihqg<G!gQOp!SVg<oge<X!uzq!d{<miGl<) 
 
Nausea (or) Vomitting 
(Glm<mz<!nz<zK!uif<kq) 
 
1 2 
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Haematuria 
 (sqXfQVme<!vk<kl<!gzf<K!!outqbikz<) 
 
Oliguria  
(sqXfQi<!Gjxf<K!-xr<Gkz<) 
 
Dysuria 
(fQi<!wiqs<sZme<!gMk<K!-xr<Gkz<) 
 
Sweating 
(uqbi<ju!Okie<Xkz<) 
 
 
 
4. Patient who are willing to sign informed consent and undergo laboratory 
investigations       
 
Criteria for Exclusion :                                                           Yes                 No 
 
5. H/o. Pregnant & lactating women        
6. H/o. Diabetes mellitus      
7. H/o. Chronic appendicitis      
8. H/o. Pyelonephritis       
9. H/o. Cholecystitis       
10. H/o. Recurrent UTI       
11. H/o. Systemic Hypertension     
12. H/o. Chronic Kidney Disease     
13. H/o. Bilateral Obstructive uropathy    
 
A patient is eligible for admission 
 If “Yes” to SI. No. 1-4                & “No” to 5-13 
 
If admitted :  OPD   IPD 
Enrolment No : _________________    Date : _________ 
 
 
_______________________    ______________________ 
  Signature of the Guide      Signature of the Investigator 
___________________ 
Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI – 2 
Department of Pothu Maruthuvam 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
 
Form IA 
 History Taking Proforma 
 
1. Enrollment Number : ____________  OP / IP: No. ______________ 
2. Chief Complaints 
Chief Complaints Present Absent Duration 
Renal Colicky Pain 
(fihqg<G!gQOp!SVg<oge<X!uzq!
d{<miGl<) 
   
Nausea (or) Vomitting 
(Glm<mz<!nz<zK!uif<kq) 
   
Haematuria 
 (sqXfQVme<!vk<kl<!gzf<K!!
outqbikz<) 
   
Oliguria  
(sqXfQi<!Gjxf<K!-xr<Gkz<) 
   
Dysuria 
(fQi<!wiqs<sZme<!gMk<K!
-xr<Gkz<) 
   
Sweating 
(uqbi<ju!Okie<Xkz<) 
   
 
Other  Presenting Complaints  Present  Absent 
If  Present Specify : ___________________________________________ 
3. History of present illness 
a. Onset of disease   1.Acute   2.Insidious 
b. Duration of disease _________________ 
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4. History of previous illness:                        Yes                    No 
a. Past illness of Urolithiasis     
i. If  Yes details __________________________________ 
b. Others       
i. If Yes details __________________________________ 
5. Family History                    Yes                       No 
a. Whether this problem runs in family   
i. If yes mention the relationship of the affected persons _______ 
b. History of previous investigation if any ________________________ 
6. Personal History 
a. Marital Status  1.Married  2.Unmarried 
b. Having Children  1.Yes   2.No 
i. If Yes Number of Children : ________________ 
c. Educational Status 
1.Illiterate   2.Semiliterate  3.Middle School 
4.Highschool  5.Higher technical education 
Others specify _________________________________ 
d. Occupational history 
1.Desk work  2.Field work 
3.Field work with intellectuals 
4.Field work with physical labours 
Indicate nature of work _________________ 
 
1 2 
1 2 
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e. Dietary Habit 
1.Vegetarian  2.Non Vegetarian    
f. Fluid intake 
                         1.  Less than 1 Litre  2. 1 – 2 Litres  
              3.  2 – 3 Litres              4. More than 3 Litres 
g. Sleep 
1.   Good 2.Disturbed  3.Insomnia 
h. Addiction                      Yes                               No 
1.Smoking:  
  If  Yes, total duration in year’s ___________ 
2.Alcohol:    
  If  Yes, total duration in year’s ___________ 
3.Tobaco chewing:     
  If  Yes, total duration in year’s ___________ 
4.Coffee / Tea / Aerated Chilled drinks :   
  If  Yes, total duration in year’s ___________ 
Any other (specify): _________________________ 
 
_______________________    ______________________ 
Signature of the Guide      Signature of the Investigator 
 
 
___________________ 
Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI - 2. 
Department of Pothu maruthuvam 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
 
Form II- Clinical Assessment Proforma 
Enrollment No : ____________  OP / IP.  No. _____________  
Date :   BFT _________ 
AFT_________ 
I. GENERAL EXAMINATION 
  Before 
Treatment 
After 
Treatment 
1. Height (cm)   
2. Weight (kg)   
3. Temperature (F°)   
4. Pulse rate (min)   
5. Heart rate (min)   
6. Respiratory rate (min)   
7. Blood Pressure (mm/Hg)   
8. BMI   
9. Anaemia   
10. Jaundice   
11. Cyanosis   
12. Lymphadenopathy   
13. Pedal edema   
14. Clubbing   
15. Jugular venous pulsation   
 
Deformities   Yes   No 
 
    If yes specify :___________________________________________________ 
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II. SYSTEMIC EXAMINATION: 
1. Urogenital system: 
a. Inspection  : 
b. Palpation   : 
c. Percussion  : 
2. Other Systems: 
a. Cardiovascular system : 
b. Respiratory system : 
c. Central Nervous system : 
d. Gastro – intestinal system: 
e. Endocrine system  : 
 
III. SIDDHA SYSTEM OF EXAMINATIONS: 
 
i.  Kaalam: 
1.Kar kaalam -  Aavani, Purattasi (Aug 15- Oct 14) 
 
2.Koothir kaalam - Iyppasi, Karthigai (Oct 15- Dec 14) 
 
3.Munpani kaalam -  Markazhi, thai (Dec 15- Feb 14) 
 
4.Pinpani kaalam -  Masi, Panguni (Feb 15 – Apr 14) 
 
5.Elavenil kaalam - Chithirai, vaikasi (Apr 15-Jun 14) 
 
6.Muthuvenil kaalam - Aani, Aadi (June 15 – Aug 14) 
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ii.  Nilam:  
S.No Land where patient lived most Place of birth 
1. Kurinji Kurinji 
2. Mullai Mullai 
3. Marutham Marutham 
4. Neithal Neithal 
5. Paalai Paalai 
 
iii. Imporigal  (Sensory Organs) 
   Before  
Treatment 
After  
Treatment 
N A N A 
1. 
Mei 
(Visumbu) 
1. Temperature 
Increased 
Decrease 
Normal 
    
2. Oedema in any parts of the body 
Present 
Absent 
    
2. Sevi (Vali) Aid of Hearing 
Normal 
Affected 
    
3. Kan (Thee) Visual disturbances 
        Yes                        No                                                
    
4. Naaku 
(Appu) 
Perception of taste 
Sweet                     Sour 
bitter                      Salt 
Astringent              Pungent 
    
5. Mookku 
(Prithivi) 
Perception of smell    N          A 
Mucous Secretion      N          A 
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iv. Kanmendheriyam (Motor Organs) 
   Before  
Treatment 
After  
Treatment 
N A N A 
1. Vai (Visumbu) 
Any Speech disturbance 
Present               Absent 
    
2. Kal (Vaayu) Any disturbance in Walking 
Present               Absent 
    
3. Kai (Thee) Any disturbances in Iduthal 
Present               Absent 
Any disturbances in Ettral 
Present               Absent 
    
4. Eruvai (Appu) Disturbances associated with 
defecation  
Present               Absent 
    
5. Karuvai  
(Prithivi) 
Having disorders of Ejaculation 
Present               Absent 
Menustration  
Present               Absent 
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v. Uyirthathukkal 
a) Vatham: 
   Before  
Treatment 
After  
Treatment 
N A N A 
1. 
Pranan 
(Vali) 
Difficulty in                    P            A 
Inspiration              
Expiration              
Sneezing                
Coughing               
Swallowing            
Spit out  
Belching 
    
2. Abanan 
(Theyu) 
Difficulty in                   P            A 
Ejaculation            
Menstruation         
Urination              
Defecation 
    
3. Vyanan 
(Veli) 
1. Difficulty in Walking  
Blinking of eyes 
Awakening 
Movements of Internal & External  
                                          organs 
2. Differentiating  the touch, Pain, 
Temperature, Pressure 
                               P            A 
 
    
4. Uthanan 
(Prithivi) 
Any changes in  Udal vanmai 
Natural immunity 
Colour of the body 
Perversion in thinking 
                               P            A 
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5. Samanan 
(Appu) 
Disturbances in Other Vayus 
Present                Absent  
Appetite   
Increased          Normal     
Decreased 
    
6. Nagan Interested in Learning 
Present                Absent  
Difficulty in Eyelid movement 
Present                Absent  
    
7. Koorman Difficulty in vision 
Present                Absent  
Difficulty in Closure mouth 
Present                Absent  
Yawning Increased 
Present                Absent  
Yawning Decreased 
Present                Absent  
Lacrimation Increased 
Present                Absent  
Lacrimation Decreased 
Present                Absent  
    
8. Kirukaran Disturbances in Nasal Secretion 
Present                Absent  
Disturbances in Salivation 
Present                Absent  
Difficulty in Sneezing  
Present                Absent  
Difficulty in Coughing 
Present                Absent  
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9. Devathathan Lack of Concentration 
Present                Absent  
Fatigue 
Present                Absent  
Anger 
Present                Absent  
    
10. Thanajeyan Dropsy 
Present                Absent  
    
 
 
b) Pitham 
   Before  
Treatment 
After  
Treatment 
N A N A 
1. Prasagam Disturbances in Digestion 
Present                Absent 
    
2. Ranjakam Changes in Colour of blood  
Pallor         Red        Blue 
    
3. Sathagam Have will power to complete the 
given task 
Present                Absent 
    
4. Alosagam Have the ability to identify the 
familiar Subjects 
Present                Absent 
    
5. Prasagam  Skin texture 
Glowing           Non Glowing 
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c)  Iyam 
   Before  
Treatment 
After  
Treatment 
N A N A 
1. Avalambagam Imbalance in Other Iyam 
Present                Absent 
    
2. Kilethagam Dryness in Mouth 
Present                Absent 
    
3. Bothagam Perversion in taste perception 
Present                Absent 
    
4. Tharpagam Burning Sensation felt in eyes 
Present                Absent 
    
5. Santhigam Restriction in movement of any 
joints 
Present                Absent 
    
 
vi) Seven Udal Thathukkal 
 Saaram 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
 Increased      
1. Indigestion Present                Absent     
2. Ex. Salivation Present                Absent 
3. Heaviness felt all 
over the body 
Present                Absent 
4. Wheezing Present                Absent 
5. Flatulence Present                Absent 
6. Cough Present                Absent 
7. Increased Sleep Present                Absent 
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 Decreased      
1. Roughness in skin Present                Absent     
2. Fatigue Present                Absent 
3. Sound intolerence Present                Absent 
4. Body pain Present                Absent 
5. Dyspnoea Present                Absent 
 
 Seneer: 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
 Increased      
1. Blisters Present                Absent     
2. Neuritis Present                Absent     
3. Loss of appetite Present                Absent     
4. Reddish eye Present                Absent     
5. Jaundice Present                Absent     
6. Psychic 
disturbance 
Present                Absent     
7. Confusion Present                Absent     
 Decreased      
1. Wish to take sour 
and chill foods 
Present                Absent     
2. Dryness Present                Absent     
3. Pallour Present                Absent     
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 Oon: 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
 Increased      
1. Increased muscular 
build around neck 
etc., 
Present                Absent     
2. Cervical adenitis Present                Absent 
3. Abscess Present                Absent 
 Decreased      
1. Fatigueness felt 
over Eyes, Nose, 
Tongue and Body 
Present                Absent     
2. Disease in joints Present                Absent 
3. Shrinkage of jaw, 
buttocks, thigh etc., 
Present                Absent 
 
 Kozhuppu:  Before  
Treatment 
After  
Treatment 
N A N A 
 Increased      
1. Dyspnoea on light 
work 
Present                Absent     
2. Flaccidity of muscle 
around thigh, chest, 
abdomen 
 
Present                Absent 
 Decreased      
1. Low back ache Present                Absent     
2. Spleenomegaly Present                Absent 
3. Loss of body weight Present                Absent 
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 Enbu: 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
 Increased      
1. Increase in number 
or growth of bones 
and teeth 
Present                Absent     
 Decreased      
1. Hairfall Present                Absent     
2. Brokened hair Present                Absent 
3. Joint pain Present                Absent 
4. Loosening of teeth Present                Absent 
 
 Moolai: 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
 Increased      
1. Dropsy Present                Absent     
2. Heaviness around 
eyes 
Present                Absent 
3. Smaller joint 
swelling esp in 
fingers and toes 
Present                Absent 
4. Oliguria Present                Absent 
5. Chronic ulcer Present                Absent 
 Decreased      
1. Osteoporosis Present                Absent     
2. Anxiety Present                Absent 
3. Darkening in visual 
field 
Present                Absent 
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 Sukkilam / 
Suronitham 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
 Increased      
1. Attractive to 
opposite sex 
Present                Absent     
2. Renal calculus Present                Absent     
 Decreased      
1. Painful coitus Present                Absent     
2. Blackish 
discolouration 
around genital 
region 
Present                Absent     
 
 
 
VII. KOSANGAL 
 
 i) Annamayakosam 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
1. Saaram Normal                Affected     
2. Seneer Normal                Affected     
3. Oon Normal                Affected     
4. Kozhuppu Normal                Affected     
5. Enbu Normal                Affected     
6. Moolai Normal                Affected     
7. Sukkilam / 
Suronitham 
Normal                Affected     
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 ii) Pranamayakosam 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
1. Pranan Normal                Affected     
2. Kai Normal                Affected     
3. Kaal Normal                Affected     
4. Vai Normal                Affected     
5. Eruvai Normal                Affected     
6. Karuvai Normal                Affected     
 
 iii) Manomayakosam 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
1. Manam Normal               Affected     
2. Sabtham Normal                Affected     
3. Sparisam Normal                Affected     
4. Rasam Normal                Affected     
5. Roobam Normal                Affected     
6. Kantham Normal                Affected     
 
 iv) Vignanamaya   
                 kosam 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
1. Buthi Normal                Affected     
2. Sabtham Normal                Affected     
3. Sparisam Normal                Affected     
4. Rasam Normal                Affected     
5. Roobam Normal                Affected     
6. Kantham Normal                Affected     
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 v) Anandamaya 
kosam: 
 
 Before  
Treatment 
After  
Treatment 
N A N A 
1. Piranan Normal                Affected     
2. Suluthi Normal                Affected     
 
8. ENVAGAI THERVUGAL 
1. Naadi:  BFT ___________ AFT _____________ 
 V  P  K   VP  VK  PV 
 PK  KV  KP  MUKKUTRAM 
 
2. Sparisam:   BFT ___________ AFT _____________ 
 Warmth  Chillness  Roughness 
 Ex. Heat  Greasy  Excessive sweat      Rashes 
 
3. Na:   BFT ___________ AFT _____________ 
 Coating  Increased Salivation   Dryness 
 Pallour   Redness    Taste perception 
 
4. Niram:  BFT ___________ AFT _____________ 
 Black   Yellow    Reddish 
 
5. Mozhi:  BFT ___________ AFT _____________ 
 
 Hoarse voice  histery voice      Stammering 
 
 
6. Vizhi:  BFT ___________ AFT _____________ 
 Palour   Reddish  Oedema  lacrimation 
 Visual disturbances        Present  Absent 
l 
 
7. Malam:  BFT ___________ AFT _____________ 
  Colour of the stools  _________________________ 
Loose stools   Present  Absent 
 Hard stools   Present  Absent 
 Pain during defecation  Present  Absent 
 Bleeding per rectum  Present  Absent 
 
8. Neer  
i) Niram:   BFT ___________ AFT _____________ 
 Yellow  Green   Black   White 
 Red  
 
ii). Manam:  BFT ___________ AFT _____________ 
  Ketotic odour  Fleshy odour     Charred odour 
 
iii). Edai:  BFT ___________ AFT _____________ 
  Haematuria   Dysuria  Resembles limestone water 
 Mixed with calcular  / fleshparts 
 
iv). Nurai:  BFT ___________ AFT _____________ 
  Increased   Decreased 
v) Enjal :   BFT ___________ AFT _____________ 
 Oliguria   Drippling 
 Polyuria   Anuria 
9. Neikuri 
   Sathiyakuri            Asathiyakuri 
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9. 14 Vegangal            Present                  Absent 
 
1. Habits of controlling  
 a. Thummal 
      b. Siruneer                
11. Thega thathuvam 
S.No  Vatham  Pitham  Kapham  
1. Physique Lean built  Medium build  Well built  
2. Strength Low strength  Medium 
strength  Good strength  
3. Complexion Glowing  dark 
or white  
pinkish or 
yellowish  
Fair, Soft 
Smooth skin  
4. Hair Black & Brokened hair  
Early graying 
yellow shades 
in hair 
 Blackish hair  
5. Eyes Rounded white 
conjuctiva  
Yellowish or 
reddish 
conjuctiva 
 
Broad and 
wide redness in 
corners 
 
6. Eyelids Thickened  Thinned  
With denser 
shining 
eyedashes 
 
7. Speech Clear-cur or 
obsure speed  
Excessive 
speech  Sound speech  
8. Sleep Less  Moderate  Sound  
9. Dream 
Activity, 
running, 
flying, 
frightening 
 
Violence, Fire, 
Anger, 
Passian, the 
sun 
 
Romance, 
Sentiment, 
Water and 
Snow 
 
10. Food intake Excessive food  Less food  Less food  
11. Likes Sweet, sour 
salt  
Sweet, 
Astringent, 
Bitter 
 
Bitter 
Astringent, 
pungent, 
 
12. Wish to take Hot foods  Cold foods  Warm foods  
13. 
Thresh 
holding 
level to 
appetite 
Less  Nil  Well  
 
 V  P  K   VP  VK  PV 
 PK  KV  KP  MUKKUTRAM 
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          THEGI_______________ 
  
12. MANOTHATHUVAM 
 
S.No Satvam  Rasatham  Thamarasm  
1. Condescension  Confidence 
(Ookam) 
 Promiscuity 
(Ozhukkanminmai) 
 
2. Controlling the 
Imporigal 
 Wisdom 
(Gnanam) 
 Lust / Fetishism 
(Kaamam) 
 
3. Wisdom  (Gnanam)  Valiant (Veeram)  Anger (Sinam)  
4. Penance (Thavam)  Moralist (Aram)  Bloodshed (kolai)  
5. Ascendant 
(Menmai) 
 Penance 
(Thavam) 
 Lazziness 
(Sombal) 
 
6. Reticence (Mounam)  Charity (Egai)  Excessive Sleep  
7. Rightness (Vaimai)  Query (Kelvi)  Gluttony (Perundi)  
 
GUNAM_______________ 
 
 
 
 
 
_____________________                  ______________________  
Signature of the Guide      Signature of the Investigator 
 
 
___________________ 
Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI - 2. 
Department of Pothu Maruthuvam 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
 
Form II A 
CLINICAL ASSESSMENT BEFORE  AND AFTER TREATMENT 
Enrollment No : ____________  OP / IP.  No. _____________  
Date :   BFT _________ 
AFT_________ 
CLINICAL SYMPTOMS 
Urolithiasis Symptom Score (USS) 
(Circle relevant number on each line) 
Symptoms Before Treatment Duration 
After Treatment days 
7th  14th  21st  28th  35th  
1. Pain / Colic 
    0 -  No Pain 
    1 – Mild Pain 
    2 – Moderate Pain 
    3 – Severe Pain 
       
2. Haematuria 
    0 -  No Haematuria 
    1 – Microscopic 
    2 – Persistent 
    3 – Gross 
       
3. Dysuria 
    0 -  No Dysuria 
    1 – Mild Dysuria 
    2 – Moderate Dysuria 
    3 – Severe Dysuria 
       
4. Stone 
    1 – Single Stone 
    2 – Multiple Stone 
       
5. Size of Stones 
    0 -  Nil 
    1 – 1 – 3 mm 
    2 –  4 – 5 mm 
    3 –  above 5mm 
       
liv 
 
6. Position of stone in kidney 
    0 -  No stone in kidney 
    1 – Pelvic ureteric junction 
    2 –  Pelvis of kidney 
    3 –  Calyces of Kidney 
       
7. Position of stone in ureter 
    0 -  No stone in ureter 
    1 – lower part in ureter 
    2 –  middle part in ureter 
    3 –  upper part in ureter 
       
8. Position of stone in bladder 
    0 -  No stone in bladder 
    1 – Base of bladder 
    2 –  Intramural  ureter 
       
 
 
Total scoring - 22 
 
1 – 7 :  Mild,  8 – 14 : Moderate,   15 – 22:  Severe 
 
Symptoms scores 
 
Before Treatment : 
 
After Treatment :  
 
 
 
_______________________    ______________________ 
Signature of the Guide      Signature of the Investigator 
 
 
 
 
 
___________________ 
Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI - 2. 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
 
Form III  
 LABORATARY INVESTIGATION PROFORMA 
 
Enrollment No : ____________  OP / IP.  No. _____________  
Date :   BFT _________ 
AFT_________ 
 
LAB INVESTIGATION 
BLOOD INVESTIGATION BT AT 
TC  (Cells / cu.mm) 
  
DC (%): 
P: 
  
L: 
  
E: 
  
 
ESR (mm/hr) 
½ hr 
  
1hr 
  
Hb (gms %): 
  
Blood Sugar 
(mg/dl): 
Fasting (F) 
  
Post Prandial 
(PP) 
  
Random (R) 
  
Blood Urea: 
  
Blood Creatinine: 
  
Serum Cholesterol: 
  
Bilirubin: 
  
URINE INVESIGATIONS   
Specific gravity 
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pH 
  
Albumin 
  
Sugar  
  
 
Deposits 
Pus cells 
  
Epithelial cells 
  
RBC’s 
  
Casts / Crystals 
  
Bile Salts :  
  
Bile Pigments: 
  
 
USG ABDOMEN AND PELVIS 
  Size of the 
Kidney 
Site of the 
Calculus 
Number of 
Calculus 
Size of the 
Calculus 
Hydronephrosis 
 
Right 
Kidney 
 
BFT 
     
 
AFT 
     
 
Left 
Kidney 
 
BFT 
     
 
AFT 
     
 
Specific Investigation: 
Stone Analysis: 
 
_______________________    ______________________ 
Signature of the Guide      Signature of the Investigator 
 
___________________ 
Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI - 2. 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
 
Form IV (A)  
PATIENT CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 
  I certify that I have disclosed all the details about the study in the terms easily 
understood by the patient. 
Name of the Investigator :  Dr. T. SEETHALAKSHMI 
                                                                                                                                                                           
Date : ......………                            Signature of the Investigator:..................................... 
       
       
CONSENT BY PATIENT 
 
I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions.  
I am also aware of my right to opt out of the trial at any time during the course of the 
trial without having to give the reasons for doing so. 
I, exercising my free power of choice, hereby give my consent to be included  
As a subject in An open labelled randomized clinical trial  of polyherbal formulation 
of Siru Nerunjil Kudineer for Kalladaippu  (Urolithiasis)  
                                                                                                                                                          
                                                                                                         
  ......................................      ...................................... 
Signature / thumb impression               Signature/thumb impression  
           of the subject                  of the witness 
 
  Name : ...............................            Name : .................................. 
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hm<mOlx<hch<H!ohiK!lVk<Kuk<Kjx/< < < < << < < < << < < < < !
gz<zjmh<H!< << << < Ofib<g<G!lVf<kig!< < << < << < < sqXofVR<sq<z<!GcfQi<< < < Q << < < Q << < < Q < 
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!
!!!!
yh<Hkz<!hcul<< < << < << < <!
Ma;thsuhy; rhd;wspf;fg;gl;lJ 
  ehd; ,e;j Ma;T Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GhpAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp :       ifnahg;gk; : 
,lk; :         ngah; :  
Ofibitqbqe<!yh<Hkz<< < << < << < <!
  vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik kw;Wk; 
kUj;Jt topKiwiag; gw;wpAk; njhlh;e;J vdJ cly; ,af;fj;ij fz;fhzpf;fTk;> 
mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l ghpNrhjidfs; gw;wp jPUg;jp 
mspf;Fk; tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; $wg;gl;lJ. 
  ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdhYk; ,e;j ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; chpikia 
njhpe;jpUf;fpNwd;. 
  ehd; vd;Dila Rje;jpukhf Njh;T nra;Ak; chpikiaf; nfhz;L fy;yilg;G ; ;; ;; ;
Neha;f;F; ;; ;; ;  “ rpWneUQ;;;;rp;y; FbePh; ; P; ; P; ; P  “ kUe;jpd; ghpfhpg;Gj;jpwidf; fz;lwpAk;  kUj;Jt 
Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;.  
 
       ifnahg;gk;: 
        ngah; :  
 
Njjp:       rhl;rpf;fhuh; ifnahg;gk; :  
,lk;:         ngah;:  
       cwTKiw :  
 
newpahsh; ifnahg;gk;    Muha;r;rpahsh; ifnahg;gk;: 
 
 
Jiwj;jiyth; ifnahg;gk; 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI – 2 
Department of Pothu Maruthuvam 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
Form IV (B) – WITHDRAWAL FORM 
 
Enrollment No: _______________               OP / IP No: _______________ 
            Date: _______________ 
 
Date of trial commencement  : _______________ 
 
Date of withdrawal from trial  : _______________ 
 
Reasons for withdrawal  :     Yes       No  
 
1. Long absence of reporting      
 
2. Irregular treatment 
 
3. Shift of locality 
 
4. Increase in severity of symptoms 
 
5. Development of severe adverse drug reactions 
 
_______________________    ______________________ 
Signature of the Guide      Signature of the Investigator 
 
___________________ 
Signature of the HOD 
 1  2 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI - 2. 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis)with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
 
Form IV (C) – PATIENT INFORMATION SHEET 
 
Name of the Investigator     : T.Seethalakshmi 
Name of the College  : Govt. Siddha Medical College & Hospital  
      Palayamkottai 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATIG IN THE OPEN 
CLINICAL TRIAL 
  I, DR.T.SEETHALAKSHMI studying  M.D(Siddha) at Govt. Siddha Medical 
College, Palayamkottai, doing a clinical trial on  “KALLADAIPPU” (Urolithiasis). You are 
invited to participate in this clinical study. The clinical study is aim to evaluate selected 
Siddha drug for its efficacy in the treatment of Urolithiasis. 
In this regard, I am in need to ask you a few questions. I will maintain confidentiality 
of your comments and data obtained. There will be no risk of disclosing your identity and no 
physical, psychological or professional risk is involved by taking part in this study. And it is 
voluntary. No compensation will be paid to your for taking part in this study. 
You can choose not to answer any specific question. There is no specific benefit for 
you if you take part in the study. However, taking part in the study may be of benefit to the 
community, as it may help us to develop medicine for KALLADAIPPU (UROLITHIASIS). 
About 40 consenting patient will be included in this study. 
KALLADAIPPU (UROLITHIASIS) is being treated in GSMC&H with many Siddha 
formulations. As a part of M.D(S) research programme and developing new efficacious 
medicine, I propose to study the SIRU NERUNJIL KUDINEER formulation for treating 
KALLADAIPPU (UROLITHIASIS). This formulation has been mentioned in siddha 
literature.                                                                                
  If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the trial drug. 
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DETAILS OF THE TRIAL DRUG: 
Trial Medicine :  Siru Nerunjil Kudineer 
Dosage :  40 ml (bd) 
Duration :  30 days. 
You can receive medicines free of cost. You have visit GSMC&H every 2 days and 
collect drugs for 2 days. After completion of 30 days the effect of treatment will be assess by 
using clinical and laboratory parameters also. 
The information I am collecting in this study will remain between you and the Co-
investigator (myself). I will ask you few questions through a questionnaire. The questionnaire 
will take approximately 20 minutes of your time. I will not write your name on this form. I 
will use a code instead. 
If you wish to find out more about this study before taking part, you can ask me all 
the questions you want or contact T. SEETHALAKSHMI, PG student (Cell No : 
9486134159) cum investigator of this study, attached to Govt. Siddha Medical College, 
Palayamkottai -2. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI – 2 
Department of Pothu Maruthuvam 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
Form IV (D) – ADVERSE DRUG REACTION FORM 
 
Enrollment No: _______________               OP / IP No: _______________ 
            Date: _______________ 
 
Date of trial commencement  : _______________ 
 
Date of withdrawal from trial  : _______________ 
 
Description of adverse reaction  :  
 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
 
 
_______________________    ______________________ 
Signature of the Guide      Signature of the Investigator 
 
 
___________________ 
Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI – 2 
Department of Pothu Maruthuvam 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
Form IV (E) – DRUG COMPLIANCE FORM 
 
Enrollment No: _______________               OP / IP No: _______________ 
            Date: _______________ 
 
Name of the drug  :  Siru Nerunjil Kudineer 
Drug issued date  :  _______________ 
Drug returned date  : _______________ 
 
Sl No DATE 
Drug given time 
(Morning Time) 
Drug given time 
(Evening Time) 
Day 1    
Day 2    
Day 3    
Day 4    
Day 5    
Day 6    
Day 7    
Day 8    
Day 9    
Day 10    
Day 11    
Day 12    
Day 13    
lxiv 
 
Day 14    
Day 15    
Day 16    
Day 17    
Day 18    
Day 19    
Day 20    
Day 21    
Day 22    
Day 23    
Day 24    
Day 25    
Day 26    
Day 27    
Day 28    
Day 29    
Day 30    
 
 
_______________________    ______________________ 
Signature of the Guide      Signature of the Investigator 
 
 
___________________ 
Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI – 2 
Department of Pothu Maruthuvam 
 
A prospective open labeled randomized clinical trial on “KALLADAIPPU” 
(Urolithiasis) with evaluation of  the trial drug “Siru Nerunjil Kudineer” 
FORM IV (F) – DIETARY ADVICE FORM 
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